<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE patent-application-publication SYSTEM "pap-v16-2002-01-01.dtd" [
<!ENTITY US20030000129A1-20030102-C00001.CDX SYSTEM "US20030000129A1-20030102-C00001.CDX" NDATA CDX>
<!ENTITY US20030000129A1-20030102-C00001.MOL SYSTEM "US20030000129A1-20030102-C00001.MOL" NDATA MOL>
<!ENTITY US20030000129A1-20030102-C00001.TIF SYSTEM "US20030000129A1-20030102-C00001.TIF" NDATA TIF>
<!ENTITY US20030000129A1-20030102-C00002.CDX SYSTEM "US20030000129A1-20030102-C00002.CDX" NDATA CDX>
<!ENTITY US20030000129A1-20030102-C00002.MOL SYSTEM "US20030000129A1-20030102-C00002.MOL" NDATA MOL>
<!ENTITY US20030000129A1-20030102-C00002.TIF SYSTEM "US20030000129A1-20030102-C00002.TIF" NDATA TIF>
<!ENTITY US20030000129A1-20030102-C00003.CDX SYSTEM "US20030000129A1-20030102-C00003.CDX" NDATA CDX>
<!ENTITY US20030000129A1-20030102-C00003.MOL SYSTEM "US20030000129A1-20030102-C00003.MOL" NDATA MOL>
<!ENTITY US20030000129A1-20030102-C00003.TIF SYSTEM "US20030000129A1-20030102-C00003.TIF" NDATA TIF>
<!ENTITY US20030000129A1-20030102-C00004.CDX SYSTEM "US20030000129A1-20030102-C00004.CDX" NDATA CDX>
<!ENTITY US20030000129A1-20030102-C00004.MOL SYSTEM "US20030000129A1-20030102-C00004.MOL" NDATA MOL>
<!ENTITY US20030000129A1-20030102-C00004.TIF SYSTEM "US20030000129A1-20030102-C00004.TIF" NDATA TIF>
<!ENTITY US20030000129A1-20030102-C00005.CDX SYSTEM "US20030000129A1-20030102-C00005.CDX" NDATA CDX>
<!ENTITY US20030000129A1-20030102-C00005.MOL SYSTEM "US20030000129A1-20030102-C00005.MOL" NDATA MOL>
<!ENTITY US20030000129A1-20030102-C00005.TIF SYSTEM "US20030000129A1-20030102-C00005.TIF" NDATA TIF>
<!ENTITY US20030000129A1-20030102-C00006.CDX SYSTEM "US20030000129A1-20030102-C00006.CDX" NDATA CDX>
<!ENTITY US20030000129A1-20030102-C00006.MOL SYSTEM "US20030000129A1-20030102-C00006.MOL" NDATA MOL>
<!ENTITY US20030000129A1-20030102-C00006.TIF SYSTEM "US20030000129A1-20030102-C00006.TIF" NDATA TIF>
<!ENTITY US20030000129A1-20030102-C00007.CDX SYSTEM "US20030000129A1-20030102-C00007.CDX" NDATA CDX>
<!ENTITY US20030000129A1-20030102-C00007.MOL SYSTEM "US20030000129A1-20030102-C00007.MOL" NDATA MOL>
<!ENTITY US20030000129A1-20030102-C00007.TIF SYSTEM "US20030000129A1-20030102-C00007.TIF" NDATA TIF>
<!ENTITY US20030000129A1-20030102-C00008.CDX SYSTEM "US20030000129A1-20030102-C00008.CDX" NDATA CDX>
<!ENTITY US20030000129A1-20030102-C00008.MOL SYSTEM "US20030000129A1-20030102-C00008.MOL" NDATA MOL>
<!ENTITY US20030000129A1-20030102-C00008.TIF SYSTEM "US20030000129A1-20030102-C00008.TIF" NDATA TIF>
<!ENTITY US20030000129A1-20030102-C00009.CDX SYSTEM "US20030000129A1-20030102-C00009.CDX" NDATA CDX>
<!ENTITY US20030000129A1-20030102-C00009.MOL SYSTEM "US20030000129A1-20030102-C00009.MOL" NDATA MOL>
<!ENTITY US20030000129A1-20030102-C00009.TIF SYSTEM "US20030000129A1-20030102-C00009.TIF" NDATA TIF>
<!ENTITY US20030000129A1-20030102-C00010.CDX SYSTEM "US20030000129A1-20030102-C00010.CDX" NDATA CDX>
<!ENTITY US20030000129A1-20030102-C00010.MOL SYSTEM "US20030000129A1-20030102-C00010.MOL" NDATA MOL>
<!ENTITY US20030000129A1-20030102-C00010.TIF SYSTEM "US20030000129A1-20030102-C00010.TIF" NDATA TIF>
<!ENTITY US20030000129A1-20030102-C00011.CDX SYSTEM "US20030000129A1-20030102-C00011.CDX" NDATA CDX>
<!ENTITY US20030000129A1-20030102-C00011.MOL SYSTEM "US20030000129A1-20030102-C00011.MOL" NDATA MOL>
<!ENTITY US20030000129A1-20030102-C00011.TIF SYSTEM "US20030000129A1-20030102-C00011.TIF" NDATA TIF>
<!ENTITY US20030000129A1-20030102-C00012.CDX SYSTEM "US20030000129A1-20030102-C00012.CDX" NDATA CDX>
<!ENTITY US20030000129A1-20030102-C00012.MOL SYSTEM "US20030000129A1-20030102-C00012.MOL" NDATA MOL>
<!ENTITY US20030000129A1-20030102-C00012.TIF SYSTEM "US20030000129A1-20030102-C00012.TIF" NDATA TIF>
]>
<patent-application-publication>
<subdoc-bibliographic-information>
<document-id>
<doc-number>20030000129</doc-number>
<kind-code>A1</kind-code>
<document-date>20030102</document-date>
</document-id>
<publication-filing-type>new</publication-filing-type>
<domestic-filing-data>
<application-number>
<doc-number>09824145</doc-number>
</application-number>
<application-number-series-code>09</application-number-series-code>
<filing-date>20010402</filing-date>
</domestic-filing-data>
<technical-information>
<classification-ipc>
<classification-ipc-primary>
<ipc>C10L005/00</ipc>
</classification-ipc-primary>
<classification-ipc-secondary>
<ipc>C07D265/00</ipc>
</classification-ipc-secondary>
<classification-ipc-edition>07</classification-ipc-edition>
</classification-ipc>
<classification-us>
<classification-us-primary>
<uspc>
<class>044</class>
<subclass>275000</subclass>
</uspc>
</classification-us-primary>
<classification-us-secondary>
<uspc>
<class>544</class>
<subclass>063000</subclass>
</uspc>
</classification-us-secondary>
</classification-us>
<title-of-invention>Transition-metal-catalyzed process for the preparation of sterically hindered N-substituted alkoxy amines</title-of-invention>
</technical-information>
<inventors>
<first-named-inventor>
<name>
<given-name>Stephen</given-name>
<middle-name>D.</middle-name>
<family-name>Pastor</family-name>
</name>
<residence>
<residence-us>
<city>Danbury</city>
<state>CT</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</first-named-inventor>
<inventor>
<name>
<given-name>Sai</given-name>
<middle-name>Ping</middle-name>
<family-name>Shum</family-name>
</name>
<residence>
<residence-us>
<city>Jamesburg</city>
<state>NJ</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
</inventors>
<correspondence-address>
<name-1>CIBA SPECIALTY CHEMICALS CORPORATION</name-1>
<name-2>PATENT DEPARTMENT</name-2>
<address>
<address-1>540 WHITE PLAINS RD</address-1>
<address-2>P O BOX 2005</address-2>
<city>TARRYTOWN</city>
<state>NY</state>
<postalcode>10591-9005</postalcode>
<country>
<country-code>US</country-code>
</country>
</address>
</correspondence-address>
</subdoc-bibliographic-information>
<subdoc-abstract>
<paragraph id="A-0001" lvl="0">Sterically hindered N-substituted alkoxyamines are prepared by the transition-metal-catalyzed decomposition of diazonium salts in the presence of a sterically hindered nitroxyl radical. These compounds are useful as thermal and light stabilizers for a variety of organic substrates. </paragraph>
</subdoc-abstract>
<subdoc-description>
<summary-of-invention>
<paragraph id="P-0001" lvl="0"><number>&lsqb;0001&rsqb;</number> This invention pertains to the novel process for preparing sterically hindered N-substituted alkoxyamines by the transition-metal-catalyzed decomposition of a diazonium salt in the present of a sterically hindered nitroxyl radical. </paragraph>
<section>
<heading lvl="1">BACKGROUND OF THE INVENTION </heading>
<paragraph id="P-0002" lvl="0"><number>&lsqb;0002&rsqb;</number> N-Aryloxyamines have been prepared in the prior art by the reaction of a phenylhydrazine with a stable nitroxide. In certain instances, N-aryloxyamines have been prepared in low yield by the decomposition of aryldiazonium salts in the presence of a nitroxyl radical, but without a transition metal catalyst being present. These papers are often about mechanistic studies with poor yields and state that the reaction described is limited in scope. A. C. Scott et al., J. Chem. Soc., Perkin Trans. 2, 1980, 260-266. </paragraph>
<paragraph id="P-0003" lvl="0"><number>&lsqb;0003&rsqb;</number> In another study, an aryl radical formed from a diazonium salt added intramolecularly to a double bond and the result alkyl radical was trapped by a stable nitroxyl radical. A. L. J. Beckwith and G. F. Meijs, J. Chem. Soc., Chem. Commun. 1981, 595-597. </paragraph>
<paragraph id="P-0004" lvl="0"><number>&lsqb;0004&rsqb;</number> It is clear that the instant process is a facile and direct way to prepare these interesting and useful instant stabilizer compounds in yields far exceeding anything found in the related prior art. Additionally, the prior art processes often use the nitroxide component as a solvent, i.e. in large excess, in contrast to the instant process. </paragraph>
<paragraph id="P-0005" lvl="0"><number>&lsqb;0005&rsqb;</number> In respect to wax stabilization, the use of selected hindered amines and/or benzotriazole UV absorbers is known in the prior art. This is seen in Japanese Hei 3-278554; WO 00/22037; and U.S. Pat. Nos. 3,530,084; 4,379,721; 4,616,051 and 5,964,905 and copending applications Ser. Nos. 09/495,495, 09/495,496 and 09/741,583. </paragraph>
</section>
<section>
<heading lvl="1">DETAILED DISCLOSURE </heading>
<paragraph id="P-0006" lvl="0"><number>&lsqb;0006&rsqb;</number> The instant invention pertains to a process for preparing a sterically hindered N-alkoxyamine of formula I, </paragraph>
<paragraph id="P-0007" lvl="7"><number>&lsqb;0007&rsqb;</number> II or III  
<chemistry-cwu id="CHEM-US-00001">
<number>1</number>
<image id="EMI-C00001" he="211.46265" wi="198.02475" file="US20030000129A1-20030102-C00001.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00001" file="US20030000129A1-20030102-C00001.CDX"/>
<chemistry-mol-file id="CHEMMOL-00001" file="US20030000129A1-20030102-C00001.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0008" lvl="7"><number>&lsqb;0008&rsqb;</number> which comprises </paragraph>
<paragraph id="P-0009" lvl="2"><number>&lsqb;0009&rsqb;</number> reacting a sterically hindered nitroxyl compound of formula IV, V or VI  
<chemistry-cwu id="CHEM-US-00002">
<number>2</number>
<image id="EMI-C00002" he="211.46265" wi="198.02475" file="US20030000129A1-20030102-C00002.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00002" file="US20030000129A1-20030102-C00002.CDX"/>
<chemistry-mol-file id="CHEMMOL-00002" file="US20030000129A1-20030102-C00002.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0010" lvl="7"><number>&lsqb;0010&rsqb;</number> with a diazonium salt of an aromatic amine of formula VII  
<chemistry-cwu id="CHEM-US-00003">
<number>3</number>
<image id="EMI-C00003" he="118.1061" wi="198.02475" file="US20030000129A1-20030102-C00003.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00003" file="US20030000129A1-20030102-C00003.CDX"/>
<chemistry-mol-file id="CHEMMOL-00003" file="US20030000129A1-20030102-C00003.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0011" lvl="7"><number>&lsqb;0011&rsqb;</number> in the presence of a transition-metal catalyst </paragraph>
<paragraph id="P-0012" lvl="7"><number>&lsqb;0012&rsqb;</number> wherein </paragraph>
<paragraph id="P-0013" lvl="2"><number>&lsqb;0013&rsqb;</number> X is &mdash;CH<highlight><subscript>2</subscript></highlight>&mdash;, &mdash;O&mdash;, &mdash;S&mdash; or &mdash;NR<highlight><subscript>8</subscript></highlight>&mdash; where R<highlight><subscript>8 </subscript></highlight>is hydrogen or alkyl of 1 to 12 carbon atoms, </paragraph>
<paragraph id="P-0014" lvl="2"><number>&lsqb;0014&rsqb;</number> R<highlight><subscript>6 </subscript></highlight>and R<highlight><subscript>7 </subscript></highlight>are independently alkyl of 1 to 8 carbon atoms, or R<highlight><subscript>6 </subscript></highlight>and R<highlight><subscript>7 </subscript></highlight>together are tetramethylene or pentamethylene,  
<chemistry-cwu id="CHEM-US-00004">
<number>4</number>
<image id="EMI-C00004" he="84.00105" wi="105.8589" file="US20030000129A1-20030102-C00004.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00004" file="US20030000129A1-20030102-C00004.CDX"/>
<chemistry-mol-file id="CHEMMOL-00004" file="US20030000129A1-20030102-C00004.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0015" lvl="0"><number>&lsqb;0015&rsqb;</number> R is hydrogen, alkyl of 1 to 18 carbon atoms, aralkyl of 7 to 15 carbon atoms, aryl of 6 to 10 carbon atoms, hydroxyl, carboxyl, amino, alkylamino of 1 to 18 carbon atoms, dialkylamino of 2 to 36 carbon atoms, oxo, alkylthio of 1 to 18 carbon atoms, alkoxy of 1 to 18 carbon atoms, aryloxy of 7 to 15 carbon atoms, alkylcarbonyloxy of 2 to 18 carbon atoms or alkylcarbonylamino of 2 to 18 carbon atoms, </paragraph>
<paragraph id="P-0016" lvl="0"><number>&lsqb;0016&rsqb;</number> G<highlight><subscript>1 </subscript></highlight>to G<highlight><subscript>4 </subscript></highlight>are independently hydrogen, halogen, nitro, cyano, alkyl of 1 to 18 carbon atoms, aralkyl of 7 to 15 carbon atoms, aryl of 6 to 10 carbon atoms, hydroxyl, carboxyl, alkylthio of 1 to 18 carbon atoms, alkoxy of 1 to 18 carbon atoms, aryloxy of 7 to 15 carbon atoms, alkylcarbonyloxy of 1 to 18 carbon atoms, alkylsulfonyl of 1 to 18 carbon atoms, arylsulfonyl of 6 to 15 carbon atoms, sulfo or phosphono, or any two vicinal substituents connected together to form a mono or polycyclic ring, so that formula VII can represent inter alia 1-naphthylamine or 2-naphthylamine. </paragraph>
<paragraph id="P-0017" lvl="0"><number>&lsqb;0017&rsqb;</number> G<highlight><subscript>5 </subscript></highlight>to G<highlight><subscript>9 </subscript></highlight>are independently hydrogen, alkyl of 1 to 18 carbon atoms, aralkyl of 7 to 15 carbon atoms or aryl of 6 to 10 carbon atoms, </paragraph>
<paragraph id="P-0018" lvl="0"><number>&lsqb;0018&rsqb;</number> In another embodiment of the instant invention, any one of G<highlight><subscript>1 </subscript></highlight>to G<highlight><subscript>9 </subscript></highlight>is phenyl. </paragraph>
<paragraph id="P-0019" lvl="0"><number>&lsqb;0019&rsqb;</number> The diazonium salt of the aromatic amine of formula VII can be prepared by reaction with an alkyl nitrite ester, such as tert-butyl nitrite. The diazonium salt can also be prepared using a nitrite salt and an acid, such as sodium nitrite and hydrochloric acid. </paragraph>
<paragraph id="P-0020" lvl="0"><number>&lsqb;0020&rsqb;</number> Indeed, the instant compounds can be made directly from nitroxides which are commercially available such as TEMPO (1-oxyl-2,2,6,6-tetramethylpiperidine), 4-OXOTEMPO (1-oxyl-2,2,6,6-tetramethyl-4-oxopiperidine) and di-tert-butyl nitroxide. </paragraph>
<paragraph id="P-0021" lvl="0"><number>&lsqb;0021&rsqb;</number> The reaction is conveniently carried out in chlorobenzene as solvent at a temperature of 0 to 100&deg; C., or between 20 and 70&deg; C. </paragraph>
<paragraph id="P-0022" lvl="0"><number>&lsqb;0022&rsqb;</number> The transition metal is a metal of Group 4, 5, 6, 7, 8, 9 or 10 of the periodic table; such as copper(I), copper(II), cobalt(II), manganese(II) or gold(I). </paragraph>
<paragraph id="P-0023" lvl="0"><number>&lsqb;0023&rsqb;</number> The process is carried out in the presence of 0.05 mole % to stoichiometric quantities of the transition metal catalyst. </paragraph>
<paragraph id="P-0024" lvl="0"><number>&lsqb;0024&rsqb;</number> The transition metal catalyst is, for example, ligated by a salcoamine ligand such as (S,S)-(&plus;)-N,N-bis(3,5-di-test-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II) or N,N-bis(salicylidene)ethylenediaminocobalt(II). </paragraph>
<paragraph id="P-0025" lvl="0"><number>&lsqb;0025&rsqb;</number> In one embodiment, X is methylene. </paragraph>
<paragraph id="P-0026" lvl="0"><number>&lsqb;0026&rsqb;</number> In another embodiment, R is hydrogen, hydroxyl, oxo or acetamido. </paragraph>
<paragraph id="P-0027" lvl="0"><number>&lsqb;0027&rsqb;</number> In still another embodiment, R<highlight><subscript>6 </subscript></highlight>and R<highlight><subscript>7 </subscript></highlight>are each methyl. </paragraph>
<paragraph id="P-0028" lvl="0"><number>&lsqb;0028&rsqb;</number> A further aspect of this invention is the addition of pyridine to the reaction mixture either as a component of the reaction mixture or as the solvent in the presence of the transition metal catalyst. Pyridine has been found to increase further the yield of the reaction as well as having superior solvent properties in certain cases. For example, when the diazonium salt is made using sodium nitrite and hydrochloric acid, pyridine also serves as a basic medium for neutralizing excess acid. </paragraph>
<paragraph id="P-0029" lvl="0"><number>&lsqb;0029&rsqb;</number> The stabilization of diazonium salts by pyridine has been reported by Heinrich Zollinger et al. (Helv. Chimica Acta, 59, 1438 (1976). Furthermore it is stated that pyridine promotes a homolytic radical pathway. Without a transition metal catalyst, however, the homolytic cleavage at 70&deg; C. is slow and is not useful. </paragraph>
<paragraph id="P-0030" lvl="0"><number>&lsqb;0030&rsqb;</number> The instant invention also pertains to a composition stabilized which comprises </paragraph>
<paragraph id="P-0031" lvl="2"><number>&lsqb;0031&rsqb;</number> (a) an organic material subject to degradation by heat, light or oxygen, and </paragraph>
<paragraph id="P-0032" lvl="2"><number>&lsqb;0032&rsqb;</number> (b) an effective stabilizing amount of a compound of formula I, II or III as described above. </paragraph>
<paragraph id="P-0033" lvl="0"><number>&lsqb;0033&rsqb;</number> Preferably, the organic material is a natural, semi-synthetic or synthetic polymer, especially a thermoplastic polymer. </paragraph>
<paragraph id="P-0034" lvl="0"><number>&lsqb;0034&rsqb;</number> Most preferably, the polymer is a polyolefin or polycarbonate, especially polyethylene or polypropylene; most especially polypropylene; or the polymer is a styrenic, ABS, a nylon, a polyester such as poly(ethylene terephthalate) or poly(butylene terephthalate), a polyurethane, an acrylate, a rubber modified styrenic, poly(vinyl chloride), poly(vinyl butyral), polyacetal (polyoxymethylene), poly(ethylene naphthalene-dicarboxylate), or other blends or copolymers such as poly(ethylene/1,4-cyclohexylene-dimethylene terephthalate) PETG or an ionomer as described on page 29. </paragraph>
<paragraph id="P-0035" lvl="0"><number>&lsqb;0035&rsqb;</number> In another preferred embodiment of the instant invention, the organic material is a resin selected from the group consisting of a thermoset acrylic melamine resin, an acrylic urethane resin, an epoxy carboxy resin, a silane modified acrylic melamine, an acrylic resin with carbamate pendant groups crosslinked with melamine or an acrylic polyol resin crosslinked with melamine containing carbamate groups. </paragraph>
<paragraph id="P-0036" lvl="0"><number>&lsqb;0036&rsqb;</number> Most preferably, the resin is a thermoset acrylic melamine resin or an acrylic urethane resin. </paragraph>
<paragraph id="P-0037" lvl="0"><number>&lsqb;0037&rsqb;</number> In yet another preferred embodiment of the instant invention, the organic material is a recording material. </paragraph>
<paragraph id="P-0038" lvl="0"><number>&lsqb;0038&rsqb;</number> The recording materials according to the invention are suitable for pressure-sensitive copying systems, photocopying systems using microcapsules, heat-sensitive copying systems, photographic materials and ink jet printing. </paragraph>
<paragraph id="P-0039" lvl="0"><number>&lsqb;0039&rsqb;</number> The recording materials according to the invention are distinguished by an unexpected improvement in quality, especially with regard to the fastness to light. </paragraph>
<paragraph id="P-0040" lvl="0"><number>&lsqb;0040&rsqb;</number> The recording materials according to the invention have the construction known for the particular use. They consist of a customary carrier, for example, paper or plastic film, which has been coated with one or more layers. Depending on the type of material, these layers contain the appropriate necessary components, in the case of photographic materials, for example, silver halide emulsions, dye couplers, dyes and the like. Material particularly suitable for ink jet printing has a layer particularly absorptive for ink on a customary carrier. Uncoated paper can also be employed for ink jet printing. In this case the paper acts at the same time as the carrier material and as the ink-absorbent layer. Suitable material for ink jet printing is, for example, described in U.S. Pat. No. 5,073,448 which is incorporated herein by reference. </paragraph>
<paragraph id="P-0041" lvl="0"><number>&lsqb;0041&rsqb;</number> The recording material can also be transparent as, for example, in the case of projection films. </paragraph>
<paragraph id="P-0042" lvl="0"><number>&lsqb;0042&rsqb;</number> The compounds of formula I, II, III or IV can be incorporated into the carder material as early as the production of the latter, in the production of paper, for example, being added to the paper pulp. A second method of application is to spray the carder material with an aqueous solution of compounds of formula I, II, III or IV or to add the compounds to the coating composition. </paragraph>
<paragraph id="P-0043" lvl="0"><number>&lsqb;0043&rsqb;</number> Coating compositions intended for transparent recording materials suitable for projection cannot contain any particles which scatter light, such as pigments and fillers. </paragraph>
<paragraph id="P-0044" lvl="0"><number>&lsqb;0044&rsqb;</number> The dye-binding coating composition can contain a number of other additives, for example, antioxidants, light stabilizers (including also UV absorbers which do not fall under the scope of the UV absorbers of this invention), viscosity improvers, fluorescent brighteners, biocides and/or antistatic agents. </paragraph>
<paragraph id="P-0045" lvl="0"><number>&lsqb;0045&rsqb;</number> The coating composition is usually prepared as follows: the water-soluble components, for example, the binder, are dissolved in water and stirred together; the solid components, for example, fillers and other additives already described, are dispersed in this aqueous medium; and disperison is advantageously carried out by means of devices, for example, ultrasonic systems, turbine stirrers, homogenizers, colloid mills, bead mills, sand mills, high-speed stirrers and the like. The compounds of formula I, II, III or IV can be easily incorporated into the coating composition. </paragraph>
<paragraph id="P-0046" lvl="0"><number>&lsqb;0046&rsqb;</number> The recording material according to this invention preferably contains 1 to 5000 mg/m<highlight><superscript>2</superscript></highlight>, in particular 50-1200 mg/m<highlight><superscript>2</superscript></highlight>, of a compound of formula I. </paragraph>
<paragraph id="P-0047" lvl="0"><number>&lsqb;0047&rsqb;</number> As already mentioned, the recording materials according to the invention embrace a wide field. The compounds of formula I, II, III or IV can, for example, be employed in pressure-sensitive copying systems. They can be introduced either into the paper in order to protect the microencapsulated dye precursors there from light, or into the binder of the developer layer in order to protect the dyes formed there. </paragraph>
<paragraph id="P-0048" lvl="0"><number>&lsqb;0048&rsqb;</number> Photocopying systems using light-sensitive microcapsules which are developed by means of pressure are described in U.S. Pat. Nos. 4,416,966; 4,483,912; 4,352,200; 4,535,050; 4,535,463; 4,551,407; 4,562,137 and 4,608,330; and also in EP-A 139,479; EP-A 162,664; EP-A 164,931; EP-A 237,024; EP-A 237,025 and EP-A 260,129. In all these systems, the compounds can be put into the dye-receiving layer. The compounds can, however, also be put into the donor layer in order to protect the color formers from light. </paragraph>
<paragraph id="P-0049" lvl="0"><number>&lsqb;0049&rsqb;</number> Photographic materials which can be stabilized are photographic dyes and layers containing such dyes or precursors thereof, for example, photographic paper and films. Suitable materials are, for example, described in U.S. Pat. No. 5,364,749 which is incorporated herein by reference. The compounds of formula I, II, III or IV act here as a UV filter against electrostatic flashes. In color photographic materials, couplers and dyes are also protected against photochemical decomposition. </paragraph>
<paragraph id="P-0050" lvl="0"><number>&lsqb;0050&rsqb;</number> The instant compounds can be used for all types of color photographic materials. For example, they can be employed for color paper, color reversal paper, direct-positive color material, color negative film, color positive film, color reversal film and the like. They are preferably used inter alia for photographic color material which contains a reversal substrate or form positives. </paragraph>
<paragraph id="P-0051" lvl="0"><number>&lsqb;0051&rsqb;</number> Color-photographic recording materials usually contain, on a support, a blue-sensitive and/or a green-sensitive and/or a red-sensitive silver halide emulsion layer and, if desired, a protection layer, with the instant compounds being, preferably, either in the green-sensitive or the red-sensitive layer or in a layer between the green-sensitive and the red-sensitive layer or in a layer on top of the silver halide emulsion layers. </paragraph>
<paragraph id="P-0052" lvl="0"><number>&lsqb;0052&rsqb;</number> The compounds of formula I, II, III or IV can also be employed in recording materials based on the principles of photopolymerization, photoplasticization or the rupture of microcapsules, or in cases where heat-sensitive and light-sensitive diazonium salts, leuko dyes having an oxidizing agent or dye lactones having Lewis acids are used. </paragraph>
<paragraph id="P-0053" lvl="0"><number>&lsqb;0053&rsqb;</number> Furthermore, the instant compounds can be employed in recording materials for dye diffusion transfer printing, thermal wax transfer printing and non-matrix printing and for use with electrostatic, electrographic, electrophoretic, magnetographic and laser-electrophotographic printers and pen-plotters. Of the above, recording materials for dye diffusion transfer printing are preferred, for example, as described in EP-A 507,734. </paragraph>
<paragraph id="P-0054" lvl="0"><number>&lsqb;0054&rsqb;</number> The instant compounds can also be employed in inks, preferably for ink jet printing, for example, as described in U.S. Pat. No. 5,098,477 which is incorporated herein by reference. </paragraph>
<paragraph id="P-0055" lvl="0"><number>&lsqb;0055&rsqb;</number> The compounds of this invention exhibit superior hydrolytic stability, handling and storage stability as well as good resistance to extractability when present in a stabilized composition. </paragraph>
<paragraph id="P-0056" lvl="0"><number>&lsqb;0056&rsqb;</number> The methodology to make the instant compounds is described in the prior art. The intermediates needed to make the instant compounds are largely items of commerce. </paragraph>
<paragraph id="P-0057" lvl="0"><number>&lsqb;0057&rsqb;</number> Preferred compounds are those in which one of X and Y is &mdash;O&mdash;; and particularly those in which both X and Y are &mdash;O&mdash;. </paragraph>
<paragraph id="P-0058" lvl="0"><number>&lsqb;0058&rsqb;</number> In general polymers which can be stabilized include </paragraph>
<paragraph id="P-0059" lvl="1"><number>&lsqb;0059&rsqb;</number> 1. Polymers of monoolefins and diolefins, for example polypropylene, polyisobutylene, polybut-1-ene, poly-4-methylpent-1-ene, polyisoprene or polybutadiene, as well as polymers of cycloolefins, for instance of cyclopentene or norbornene, polyethylene (which optionally can be crosslinked), for example high density polyethylene (HDPE), low density polyethylene (LDPE), linear low density polyethylene (LLDPE), branched low density polyethylene (BLDPE). </paragraph>
<paragraph id="P-0060" lvl="7"><number>&lsqb;0060&rsqb;</number> Polyolefins, i.e. the polymers of monoolefins exemplified in the preceding paragraph, preferably polyethylene and polypropylene, can be prepared by different, and especially by the following, methods: </paragraph>
<paragraph id="P-0061" lvl="2"><number>&lsqb;0061&rsqb;</number> a) radical polymerisation (normally under high pressure and at elevated temperature). </paragraph>
<paragraph id="P-0062" lvl="2"><number>&lsqb;0062&rsqb;</number> b) catalytic polymerisation using a catalyst that normally contains one or more than one metal of groups IVb, Vb, VIb or VIII of the Periodic Table. These metals usually have one or more than one ligand, typically oxides, halides, alcoholates, esters, ethers, amines, alkyls, alkenyls and/or aryls that may be either &pgr;- or &sgr;-coordinated. These metal complexes may be in the free form or fixed on substrates, typically on activated magnesium chloride, titanium(III) chloride, alumina or silicon oxide. These catalysts may be soluble or insoluble in the polymerisation medium. The catalysts can be used by themselves in the polymerisation or further activators may be used, typically metal alkyls, metal hydrides, metal alkyl halides, metal alkyl oxides or metal alkyloxanes, said metals being elements of groups Ia, Ila and/or IIIa of the Periodic Table. The activators may be modified conveniently with further ester, ether, amine or silyl ether groups. These catalyst systems are usually termed Phillips, Standard Oil Indiana, Ziegler (-Natta), TNZ (DuPont), metallocene or single site catalysts (SSC). </paragraph>
<paragraph id="P-0063" lvl="1"><number>&lsqb;0063&rsqb;</number> 2. Mixtures of the polymers mentioned under 1), for example mixtures of polypropylene with polyisobutylene, polypropylene with polyethylene (for example PP/HDPE, PP/LDPE) and mixtures of different types of polyethylene (for example LDPE/HDPE). </paragraph>
<paragraph id="P-0064" lvl="1"><number>&lsqb;0064&rsqb;</number> 3. Copolymers of monoolefins and diolefins with each other or with other vinyl monomers, for example ethylene/propylene copolymers, linear low density polyethylene (LLDPE) and mixtures thereof with low density polyethylene (LDPE), propylene/but-1-ene copolymers, propylene/isobutylene copolymers, ethylene/but-l-ene copolymers, ethylene/hexene copolymers, ethylene/methylpentene copolymers, ethylene/heptene copolymers, ethylene/octene copolymers, propylene/butadiene copolymers, isobutylene/isoprene copolymers, ethylene/alkyl acrylate copolymers, ethylene/alkyl methacrylate copolymers, ethylene/vinyl acetate copolymers and their copolymers with carbon monoxide or ethylene/acrylic acid copolymers and their salts (ionomers) as well as terpolymers of ethylene with propylene and a diene such as hexadiene, dicyclopentadiene or ethylidene-norbornene; and mixtures of such copolymers with one another and with polymers mentioned in 1) above, for example polypropylene/ethylene-propylene copolymers, LDPE/ethylene-vinyl acetate copolymers (EVA), LDPE/ethylene-acrylic acid copolymers (EAA), LLDPE/EVA, LLDPE/EAA and alternating or random polyalkylene/carbon monoxide copolymers and mixtures thereof with other polymers, for example polyamides. </paragraph>
<paragraph id="P-0065" lvl="1"><number>&lsqb;0065&rsqb;</number> 4. Hydrocarbon resins (for example C<highlight><subscript>5</subscript></highlight>-C<highlight><subscript>9</subscript></highlight>) including hydrogenated modifications thereof (e.g. tackifiers) and mixtures of polyalkylenes and starch. </paragraph>
<paragraph id="P-0066" lvl="1"><number>&lsqb;0066&rsqb;</number> 5. Polystyrene, poly(p-methylstyrene), poly(&agr;-methylstyrene). </paragraph>
<paragraph id="P-0067" lvl="1"><number>&lsqb;0067&rsqb;</number> 6. Copolymers of styrene or &agr;-methylstyrene with dienes or acrylic derivatives, for example styrene/butadiene, styrene/acrylonitrile, styrene/alkyl methacrylate, styrene/butadiene/alkyl acrylate, styrene/butadiene/alkyl methacrylate, styrene/maleic anhydride, styrene/acrylonitrile/methyl acrylate; mixtures of high impact strength of styrene copolymers and another polymer, for example a polyacrylate, a diene polymer or an ethylene/propylene/diene terpolymer, and block copolymers of styrene such as styrene/butadiene/styrene, styrene/isoprene/styrene, styrene/ethylene/butylene/styrene or styrene/ethylene/propylene/styrene. </paragraph>
<paragraph id="P-0068" lvl="1"><number>&lsqb;0068&rsqb;</number> 7. Graft copolymers of styrene or a-methylstyrene, for example styrene on polybutadiene, styrene on polybutadiene-styrene or polybutadiene-acrylonitrile copolymers; styrene and acrylonitrile (or methacrylonitrile) on polybutadiene; styrene, acrylonitrile and methyl methacrylate on polybutadiene; styrene and maleic anhydride on polybutadiene; styrene, acrylonitrile and maleic anhydride or maleimide on polybutadiene; styrene and maleimide on polybutadiene; styrene and alkyl acrylates or methacrylates on polybutadiene; styrene and acrylonitrile on ethylene/propylene/diene terpolymers; styrene and acrylonitrile on polyalkyl acrylates or polyalkyl methacrylates, styrene and acrylonitrile on acrylate/butadiene copolymers, as well as mixtures thereof with the copolymers listed under 6), for example the copolymer mixtures known as ABS, MBS, ASA or AES polymers. </paragraph>
<paragraph id="P-0069" lvl="1"><number>&lsqb;0069&rsqb;</number> 8. Halogen-containing polymers such as polychloroprene, chlorinated rubbers, chlorinated or sulfochlorinated polyethylene, copolymers of ethylene and chlorinated ethylene, epichlorohydrin homo- and copolymers, especially polymers of halogen-containing vinyl compounds, for example polyinyl chloride, polyinylidene chloride, polyinyl fluoride, polyinylidene fluoride, as well as copolymers thereof such as vinyl chloride/vinylidene chloride, vinyl chloride/vinyl acetate or vinylidene chloride/vinyl acetate copolymers. </paragraph>
<paragraph id="P-0070" lvl="1"><number>&lsqb;0070&rsqb;</number> 9. Polymers derived from &agr;,&bgr;-unsaturated acids and derivatives thereof such as polyacrylates and polymethacrylates; polymethyl methacrylates, polyacrylamides and polyacrylonitriles, impact-modified with butyl acrylate. </paragraph>
<paragraph id="P-0071" lvl="1"><number>&lsqb;0071&rsqb;</number> 10. Copolymers of the monomers mentioned under 9) with each other or with other unsaturated monomers, for example acrylonitrile/butadiene copolymers, acrylonitrile/alkyl acrylate copolymers, acrylonitrile/alkoxyalkyl acrylate or acrylonitrile/vinyl halide copolymers or acrylonitrile/alkyl methacrylate/butadiene terpolymers. </paragraph>
<paragraph id="P-0072" lvl="1"><number>&lsqb;0072&rsqb;</number> 11. Polymers derived from unsaturated alcohols and amines or the acyl derivatives or acetals thereof, for example polyinyl alcohol, polyinyl acetate, polyinyl stearate, polyvinyl benzoate, polyinyl maleate, polyinyl butyral, polyallyl phthalate or polyallyl melamine; as well as their copolymers with olefins mentioned in 1) above. </paragraph>
<paragraph id="P-0073" lvl="1"><number>&lsqb;0073&rsqb;</number> 12. Homopolymers and copolymers of cyclic ethers such as polyalkylene glycols, polyethylene oxide, polypropylene oxide or copolymers thereof with bisglycidyl ethers. </paragraph>
<paragraph id="P-0074" lvl="1"><number>&lsqb;0074&rsqb;</number> 13. Polyacetals such as polyoxymethylene and those polyoxymethylenes which contain ethylene oxide as a comonomer, polyacetals modified with thermoplastic polyurethanes, acrylates or MBS. </paragraph>
<paragraph id="P-0075" lvl="1"><number>&lsqb;0075&rsqb;</number> 14. Polyphenylene oxides and sulfides, and mixtures of polyphenylene oxides with styrene polymers or polyamides. </paragraph>
<paragraph id="P-0076" lvl="1"><number>&lsqb;0076&rsqb;</number> 15. Polyurethanes derived from hydroxyl-terminated polyethers, polyesters or polybutadienes on the one hand and aliphatic or aromatic polyisocyanates on the other, as well as precursors thereof. </paragraph>
<paragraph id="P-0077" lvl="1"><number>&lsqb;0077&rsqb;</number> 16. Polyamides and copolyamides derived from diamines and dicarboxylic acids and/or from aminocarboxylic acids or the corresponding lactams, for example polyamide 4, polyamide 6, polyamide 6/6, 6/10, 6/9, 6/12, 4/6, 12/12, polyamide 11, polyamide 12, aromatic polyamides starting from m-xylene diamine and adipic acid; polyamides prepared from hexamethylenediamine and isophthalic or/and terephthalic acid and with or without an elastomer as modifier, for example poly-2,4,4,-trimethylhexamethylene terephthalamide or poly-m-phenylene isophthalamide; and also block copolymers of the aforementioned polyamides with polyolefins, olefin copolymers, ionomers or chemically bonded or grafted elastomers; or with polyethers, e.g. with polyethylene glycol, polypropylene glycol or polytetramethylene glycol; as well as polyamides or copolyamides modified with EPDM or ABS; and polyamides condensed during processing (RIM polyamide systems). </paragraph>
<paragraph id="P-0078" lvl="1"><number>&lsqb;0078&rsqb;</number> 17. Polyureas, polyimides, polyamide-imides and polybenzimidazoles. </paragraph>
<paragraph id="P-0079" lvl="1"><number>&lsqb;0079&rsqb;</number> 18. Polyesters derived from dicarboxylic acids and diols and/or from hydroxycarboxylic acids or the corresponding lactones, for example polyethylene terephthalate, polybutylene terephthalate, poly-1,4-dimethylolcyclohexane terephthalate and polyhydroxybenzoates, as well as block copolyether esters derived from hydroxyl-terminated polyethers; and also polyesters modified with polycarbonates or MBS. </paragraph>
<paragraph id="P-0080" lvl="1"><number>&lsqb;0080&rsqb;</number> 19. Polycarbonates and polyester carbonates. </paragraph>
<paragraph id="P-0081" lvl="1"><number>&lsqb;0081&rsqb;</number> 20. Polysulfones, polyether sulfones and polyether ketones. </paragraph>
<paragraph id="P-0082" lvl="1"><number>&lsqb;0082&rsqb;</number> 21. Crosslinked polymers derived from aldehydes on the one hand and phenols, ureas and melamines on the other hand, such as phenol/formaldehyde resins, urea/formaldehyde resins and melamine/formaldehyde resins. </paragraph>
<paragraph id="P-0083" lvl="1"><number>&lsqb;0083&rsqb;</number> 22. Drying and non-drying alkyd resins. </paragraph>
<paragraph id="P-0084" lvl="1"><number>&lsqb;0084&rsqb;</number> 23. Unsaturated polyester resins derived from copolyesters of saturated and unsaturated dicarboxylic acids with polyhydric alcohols and vinyl compounds as crosslinking agents, and also halogen-containing modifications thereof of low flammability. </paragraph>
<paragraph id="P-0085" lvl="1"><number>&lsqb;0085&rsqb;</number> 24. Crosslinkable acrylic resins derived from substituted acrylates, for example epoxy acrylates, urethane acrylates or polyester acrylates. </paragraph>
<paragraph id="P-0086" lvl="1"><number>&lsqb;0086&rsqb;</number> 25. Alkyd resins, polyester resins and acrylate resins crosslinked with melamine resins, urea resins, polyisocyanates or epoxy resins. </paragraph>
<paragraph id="P-0087" lvl="1"><number>&lsqb;0087&rsqb;</number> 26. Crosslinked epoxy resins derived from polyepoxides, for example from bisglycidyl ethers or from cycloaliphatic diepoxides. </paragraph>
<paragraph id="P-0088" lvl="1"><number>&lsqb;0088&rsqb;</number> 27. Natural polymers such as cellulose, rubber, gelatin and chemically modified homologous derivatives thereof, for example cellulose acetates, cellulose propionates and cellulose butyrates, or the cellulose ethers such as methyl cellulose; as well as rosins and their derivatives. </paragraph>
<paragraph id="P-0089" lvl="1"><number>&lsqb;0089&rsqb;</number> 28. Blends of the aforementioned polymers (polyblends), for example PP/EPDM, Polyamide/EPDM or ABS, PVC/EVA, PVC/ABS, PVC/MBS, PC/ABS, PBTP/ABS, PC/ASA, PC/PBT, PVC/CPE, PVC/acrylates, POM/thermoplastic PUR, PC/thermoplastic PUR, POM/acrylate, POM/MBS, PPO/HIPS, PPO/PA 6.6 and copolymers, PA/HDPE, PA/PP, PA/PPO. </paragraph>
<paragraph id="P-0090" lvl="1"><number>&lsqb;0090&rsqb;</number> 29. Naturally occurring and synthetic organic materials which are pure monomeric compounds or mixtures of such compounds, for example mineral oils, animal and vegetable fats, oil and waxes, or oils, fats and waxes based on synthetic esters (e.g. phthalates, adipates, phosphates or trimellitates) and also mixtures of synthetic esters with mineral oils in any weight ratios, typically those used as spinning compositions, as well as aqueous emulsions of such materials. </paragraph>
<paragraph id="P-0091" lvl="1"><number>&lsqb;0091&rsqb;</number> 30. Aqueous emulsions of natural or synthetic rubber, e.g. natural latex or latices of carboxylated styrene/butadiene copolymers. </paragraph>
<paragraph id="P-0092" lvl="1"><number>&lsqb;0092&rsqb;</number> 31. Polysiloxanes such as the soft, hydrophilic polysiloxanes described, for example, in U.S. Pat. No. 4,259,467; and the hard polyorganosiloxanes described, for example, in U.S. Pat. No. 4,355,147. </paragraph>
<paragraph id="P-0093" lvl="1"><number>&lsqb;0093&rsqb;</number> 32. Polyketimines in combination with unsaturated acrylic polyacetoacetate resins or with unsaturated acrylic resins. The unsaturated acrylic resins include the urethane acrylates, polyether acrylates, vinyl or acryl copolymers with pendant unsaturated groups and the acrylated melamines. The polyketimines are prepared from polyamines and ketones in the presence of an acid catalyst. </paragraph>
<paragraph id="P-0094" lvl="1"><number>&lsqb;0094&rsqb;</number> 33. Radiation curable compositions containing ethylenically unsaturated monomers or oligomers and a polyunsaturated aliphatic oligomer. </paragraph>
<paragraph id="P-0095" lvl="1"><number>&lsqb;0095&rsqb;</number> 34. Epoxymelamine resins such as light-stable epoxy resins crosslinked by an epoxy functional coetherified high solids melamine resin such as LSE-4103 (Monsanto). </paragraph>
<paragraph id="P-0096" lvl="0"><number>&lsqb;0096&rsqb;</number> In general, the compounds of the present invention are employed in from about 0.01 to about 5% by weight of the stabilized composition, although this will vary with the particular substrate and application. An advantageous range is from about 0.05 to about 3%, and especially 0.05 to about 1%. However, some high performance films or in UV absorbing layers of laminates such as those produced by coextrusion may contain from 5-15% by weight of the instant compounds. Concentrations of 5-10% by weight are typical in certain coextrusion applications. </paragraph>
<paragraph id="P-0097" lvl="0"><number>&lsqb;0097&rsqb;</number> The stabilizers of the instant invention may readily be incorporated into the organic polymers by conventional techniques, at any convenient stage prior to the manufacture of shaped articles therefrom. For example, the stabilizer may be mixed with the polymer in dry powder form, or a suspension or emulsion of the stabilizer may be mixed with a solution, suspension, or emulsion of the polymer. The resulting stabilized polymer compositions of the invention may optionally also contain from about 0.01 to about 5%, preferably from about 0.025 to about 2%, and especially from about 0.1 to about 1% by weight of various conventional additives, such as the materials listed below, or mixtures thereof. </paragraph>
<paragraph id="P-0098" lvl="7"><number>&lsqb;0098&rsqb;</number> 1. Antioxidants </paragraph>
<paragraph id="P-0099" lvl="7"><number>&lsqb;0099&rsqb;</number> 1.1. Alkylated Monophenols, for Example, </paragraph>
<paragraph id="P-0100" lvl="1"><number>&lsqb;0100&rsqb;</number> 2,6-di-tert-butyl-4-methylphenol </paragraph>
<paragraph id="P-0101" lvl="1"><number>&lsqb;0101&rsqb;</number> 2-tert-butyl-4,6-dimethylphenol </paragraph>
<paragraph id="P-0102" lvl="1"><number>&lsqb;0102&rsqb;</number> 2,6-di-tert-butyl-4-ethylphenol </paragraph>
<paragraph id="P-0103" lvl="1"><number>&lsqb;0103&rsqb;</number> 2,6-di-tert-butyl-4-n-butylphenol </paragraph>
<paragraph id="P-0104" lvl="1"><number>&lsqb;0104&rsqb;</number> 2,6-di-tert-butyl-4-i-butylphenol </paragraph>
<paragraph id="P-0105" lvl="1"><number>&lsqb;0105&rsqb;</number> 2,6-di-cyclopentyl-4-methylphenol </paragraph>
<paragraph id="P-0106" lvl="1"><number>&lsqb;0106&rsqb;</number> 2-(&agr;-methylcyclohexyl)-4,6-dimethylphenol </paragraph>
<paragraph id="P-0107" lvl="1"><number>&lsqb;0107&rsqb;</number> 2,6-di-octadecyl-4-methylphenol </paragraph>
<paragraph id="P-0108" lvl="1"><number>&lsqb;0108&rsqb;</number> 2,4,6-tri-cyclohexylphenol </paragraph>
<paragraph id="P-0109" lvl="1"><number>&lsqb;0109&rsqb;</number> 2,6-di-tert-butyl-4-methoxymethylphenol </paragraph>
<paragraph id="P-0110" lvl="7"><number>&lsqb;0110&rsqb;</number> 1.2. Alkylated Hydroquinones, for Example, </paragraph>
<paragraph id="P-0111" lvl="1"><number>&lsqb;0111&rsqb;</number> 2,6-di-tert-butyl-4-methoxyphenol </paragraph>
<paragraph id="P-0112" lvl="1"><number>&lsqb;0112&rsqb;</number> 2,5-di-tert-butyl-hydroquinone </paragraph>
<paragraph id="P-0113" lvl="1"><number>&lsqb;0113&rsqb;</number> 2,5-di-tert-amyl-hydroquinone </paragraph>
<paragraph id="P-0114" lvl="1"><number>&lsqb;0114&rsqb;</number> 2,6-diphenyl-4-octadecyloxyphenol </paragraph>
<paragraph id="P-0115" lvl="7"><number>&lsqb;0115&rsqb;</number> 1.3. Hydroxylated Thiodiphenyl Ethers, for Example, </paragraph>
<paragraph id="P-0116" lvl="1"><number>&lsqb;0116&rsqb;</number> 2,2&prime;-thio-bis-(6-tert-butyl-4-methylphenol) </paragraph>
<paragraph id="P-0117" lvl="1"><number>&lsqb;0117&rsqb;</number> 2,2&prime;-thio-bis-(4-octylphenol) </paragraph>
<paragraph id="P-0118" lvl="1"><number>&lsqb;0118&rsqb;</number> 4,4&prime;-thio-bis-(6-tert-butyl-3-methylphenol) </paragraph>
<paragraph id="P-0119" lvl="1"><number>&lsqb;0119&rsqb;</number> 4,4&prime;-thio-bis-(6-tert-butyl-2-methylphenol) </paragraph>
<paragraph id="P-0120" lvl="7"><number>&lsqb;0120&rsqb;</number> 1.4. Alkylidene-bisphenols, for Example, </paragraph>
<paragraph id="P-0121" lvl="1"><number>&lsqb;0121&rsqb;</number> 2,2&prime;-methylene-bis-(6-tert-butyl-4-methylphenol) </paragraph>
<paragraph id="P-0122" lvl="1"><number>&lsqb;0122&rsqb;</number> 2,2&prime;-methylene-bis-(6-tert-butyl-4-ethylphenol) </paragraph>
<paragraph id="P-0123" lvl="1"><number>&lsqb;0123&rsqb;</number> 2,2&prime;-methylene-bis-&lsqb;4-methyl-6-(&agr;-methylcyclohexyl)-phenol&rsqb;</paragraph>
<paragraph id="P-0124" lvl="1"><number>&lsqb;0124&rsqb;</number> 2,2&prime;-methylene-bis-(4-m ethyl-6-cyclohexylphenol) </paragraph>
<paragraph id="P-0125" lvl="1"><number>&lsqb;0125&rsqb;</number> 2,2&prime;-methylene-bis-(6-nonyl-4-methylphenol) </paragraph>
<paragraph id="P-0126" lvl="1"><number>&lsqb;0126&rsqb;</number> 2,2&prime;-methylene-bis-&lsqb;6-(&agr;-methylbenzyl)-4-nonylphenol&rsqb;</paragraph>
<paragraph id="P-0127" lvl="1"><number>&lsqb;0127&rsqb;</number> 2,2&prime;-methylene-bis-&lsqb;6-(&agr;,&agr;-dimethylbenzyl)-4-nonylphenol&rsqb;</paragraph>
<paragraph id="P-0128" lvl="1"><number>&lsqb;0128&rsqb;</number> 2,2&prime;-methylene-bis-(4,6-di-tert-butylphenol) </paragraph>
<paragraph id="P-0129" lvl="1"><number>&lsqb;0129&rsqb;</number> 2,2&prime;-ethylidene-bis-(4,6-di-tert-butylphenol) </paragraph>
<paragraph id="P-0130" lvl="1"><number>&lsqb;0130&rsqb;</number> 2,2&prime;-ethylidene-bis-(6-tert-butyl-4-isobutylphenol) </paragraph>
<paragraph id="P-0131" lvl="1"><number>&lsqb;0131&rsqb;</number> 4,4&prime;-methylene-bis-(2,6-di-tert-butylphenol) </paragraph>
<paragraph id="P-0132" lvl="1"><number>&lsqb;0132&rsqb;</number> 4,4&prime;-methylene-bis-(6-tert-butyl-2-methylphenol) </paragraph>
<paragraph id="P-0133" lvl="1"><number>&lsqb;0133&rsqb;</number> 1,1-bis-(5-tert-butyl-4-hydroxy-2-methylphenyl)-butane </paragraph>
<paragraph id="P-0134" lvl="1"><number>&lsqb;0134&rsqb;</number> 2,6-di-(3-tert-butyl-5-methyl-2-hydroxybenzyl)-4-methylphenol </paragraph>
<paragraph id="P-0135" lvl="1"><number>&lsqb;0135&rsqb;</number> 1,1,3-tris-(5-tert-butyl-4-hydroxy-2-methylphenyl)-butane </paragraph>
<paragraph id="P-0136" lvl="1"><number>&lsqb;0136&rsqb;</number> 1,1-bis-(5-tert-butyl-4-hydroxy-2-methylphenyl)-3-n-dodecylmercaptobutane </paragraph>
<paragraph id="P-0137" lvl="1"><number>&lsqb;0137&rsqb;</number> ethyleneglycol bis-&lsqb;3,3-bis-(3&prime;-tert-butyl-4&prime;-hydroxyphenyl)-butyrate&rsqb;</paragraph>
<paragraph id="P-0138" lvl="1"><number>&lsqb;0138&rsqb;</number> di-(3-tert-butyl-4-hydroxy-5-methylphenyl)-dicyclopentadiene </paragraph>
<paragraph id="P-0139" lvl="1"><number>&lsqb;0139&rsqb;</number> di-&lsqb;2-(3&prime;-tert-butyl-2&prime;-hydroxy-5&prime;-methyl-benzyl)-6-tert-butyl-4-methylphenyl&rsqb;terephthalate. </paragraph>
<paragraph id="P-0140" lvl="7"><number>&lsqb;0140&rsqb;</number> 1.5. Benzyl Compounds, for Example, </paragraph>
<paragraph id="P-0141" lvl="1"><number>&lsqb;0141&rsqb;</number> 1,3,5-tri-(3,5-di-tert-butyl-4-hydroxybenzyl)-2,4,6-trimethylbenzene </paragraph>
<paragraph id="P-0142" lvl="1"><number>&lsqb;0142&rsqb;</number> di-(3,5-di-tert-butyl-4-hydroxybenzyl) sulfide </paragraph>
<paragraph id="P-0143" lvl="1"><number>&lsqb;0143&rsqb;</number> 3,5-di-tert-butyl-4-hydroxybenzyl-mercapto-acetic acid isooctyl ester </paragraph>
<paragraph id="P-0144" lvl="1"><number>&lsqb;0144&rsqb;</number> bis-(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl)dithiol terephthalate </paragraph>
<paragraph id="P-0145" lvl="1"><number>&lsqb;0145&rsqb;</number> 1,3,5-tris-(3,5-di-tert-butyl-4-hydroxybenzyl) isocyanurate </paragraph>
<paragraph id="P-0146" lvl="1"><number>&lsqb;0146&rsqb;</number> 1,3,5-tris-(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl) isocyanurate </paragraph>
<paragraph id="P-0147" lvl="1"><number>&lsqb;0147&rsqb;</number> 3,5-di-tert-butyl-4-hydroxybenzyl-phosphoric acid dioctadecyl ester </paragraph>
<paragraph id="P-0148" lvl="1"><number>&lsqb;0148&rsqb;</number> 3,5-di-tert-butyl-4-hydroxybenzyl-phosphoric acid monoethyl ester, calcium-salt </paragraph>
<paragraph id="P-0149" lvl="7"><number>&lsqb;0149&rsqb;</number> 1.6. Acylaminophenols, for Example, </paragraph>
<paragraph id="P-0150" lvl="1"><number>&lsqb;0150&rsqb;</number> 4-hydroxy-lauric acid anilide </paragraph>
<paragraph id="P-0151" lvl="1"><number>&lsqb;0151&rsqb;</number> 4-hydroxy-stearic acid anilide </paragraph>
<paragraph id="P-0152" lvl="1"><number>&lsqb;0152&rsqb;</number> 2,4-bis-octylmercapto-6-(3,5-tert-butyl-4-hydroxyanilino)-s-triazine </paragraph>
<paragraph id="P-0153" lvl="1"><number>&lsqb;0153&rsqb;</number> octyl-N-(3,5-di-tert-butyl-4-hydroxyphenyl)-carbamate </paragraph>
<paragraph id="P-0154" lvl="7"><number>&lsqb;0154&rsqb;</number> 1.7. Esters of &bgr;-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionic Acid with Monohydric or Polyhydric Alcohols, for Example,  
<table-cwu id="TABLE-US-00001">
<number>1</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="84PT" align="left"/>
<colspec colname="2" colwidth="119PT" align="left"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
<entry>methanol</entry>
<entry>diethylene glycol</entry>
</row>
<row>
<entry></entry>
<entry>octadecanol</entry>
<entry>triethylene glycol</entry>
</row>
<row>
<entry></entry>
<entry>1,6-hexanediol</entry>
<entry>pentaerythritol</entry>
</row>
<row>
<entry></entry>
<entry>neopentyl glycol</entry>
<entry>tris-hydroxyethyl isocyanurate</entry>
</row>
<row>
<entry></entry>
<entry>thiodiethylene glycol</entry>
<entry>di-hydroxyethyl oxalic acid diamide</entry>
</row>
<row>
<entry></entry>
<entry>triethanolamine</entry>
<entry>triisopropanolamine</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0155" lvl="7"><number>&lsqb;0155&rsqb;</number> 1.8. Esters of &bgr;-(5-tert-butyl-4-hydroxy-3-methylphenyl)-propionic Acid with Monohydric or Polyhydric Alcohols, for Example,  
<table-cwu id="TABLE-US-00002">
<number>2</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="84PT" align="left"/>
<colspec colname="2" colwidth="119PT" align="left"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
<entry>methanol</entry>
<entry>diethylene glycol</entry>
</row>
<row>
<entry></entry>
<entry>octadecanol</entry>
<entry>triethylene glycol</entry>
</row>
<row>
<entry></entry>
<entry>1,6-hexanediol</entry>
<entry>pentaerythritol</entry>
</row>
<row>
<entry></entry>
<entry>neopentyl glycol</entry>
<entry>tris-hydroxyethyl isocyanurate</entry>
</row>
<row>
<entry></entry>
<entry>thiodiethylene glycol</entry>
<entry>di-hydroxyethyl oxalic acid diamide</entry>
</row>
<row>
<entry></entry>
<entry>triethanolamine</entry>
<entry>triisopropanolamine</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0156" lvl="7"><number>&lsqb;0156&rsqb;</number> 1.9. Amides of &bgr;-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionic Acid for Example, </paragraph>
<paragraph id="P-0157" lvl="1"><number>&lsqb;0157&rsqb;</number> N,N&prime;-di-(3,5-di-tert-butyl-4-hydroxyphenylpropionyl)-hexamethylenediamine </paragraph>
<paragraph id="P-0158" lvl="1"><number>&lsqb;0158&rsqb;</number> N,N&prime;-di-(3,5-di-tert-butyl-4-hydroxyphenylpropionyl)-trimethylenediamine </paragraph>
<paragraph id="P-0159" lvl="1"><number>&lsqb;0159&rsqb;</number> N,N&prime;-di-(3,5-di-tert-butyl-4-hydroxyphenylpropionyl)-hydrazine </paragraph>
<paragraph id="P-0160" lvl="7"><number>&lsqb;0160&rsqb;</number> 1.10 Diarylamines, for Example, </paragraph>
<paragraph id="P-0161" lvl="1"><number>&lsqb;0161&rsqb;</number> diphenylamine, N-phenyl-1-naphthylamine, N-(4-tert-octylphenyl)-1-naphthylamine, </paragraph>
<paragraph id="P-0162" lvl="1"><number>&lsqb;0162&rsqb;</number> 4,4&prime;-di-tert-octyl-diphenylamine, reaction product of N-phenylbenzylamine and </paragraph>
<paragraph id="P-0163" lvl="1"><number>&lsqb;0163&rsqb;</number> 2,4,4-trimethylpentene, reaction product of diphenylamine and 2,4,4-trimethylpentene, reaction product of N-phenyl-1-naphthylamine and 2,4,4-trimethylpentene. </paragraph>
<paragraph id="P-0164" lvl="7"><number>&lsqb;0164&rsqb;</number> 2. UV Absorbers and Light Stabilizers </paragraph>
<paragraph id="P-0165" lvl="7"><number>&lsqb;0165&rsqb;</number> 2.1. 2-(2&prime;-Hydroxyphenyl)-benzotriazoles, </paragraph>
<paragraph id="P-0166" lvl="7"><number>&lsqb;0166&rsqb;</number> for example, the 5&prime;-methyl-, 3&prime;,5&prime;-di-tert-butyl-, 5&prime;-tert-butyl-, 5&prime;-(1,1,3,3-tetramethylbutyl)-, 5-chloro-3&prime;,5&prime;-di-tert-butyl-, 5-chloro-3&prime;-tert-butyl-5&prime;-methyl-, 3&prime;-sec-butyl-5&prime;-tert-butyl-, 4&prime;-octoxy, 3&prime;,5&prime;-di-tert-amyl-, 3&prime;,5&prime;-bis-(&agr;,&agr;-dimethylbenzyl), 3&prime;-tert-butyl-5&prime;-(2-(omega-hydroxy-octa-(ethyleneoxy)carbonyl-ethyl)-, 3&prime;-dodecyl-5&prime;-methyl-, and 3&prime;-tert-butyl-5&prime;-(2-octyloxycarbonyl)ethyl-, and dodecylated-5&prime;-methyl derivatives. </paragraph>
<paragraph id="P-0167" lvl="7"><number>&lsqb;0167&rsqb;</number> 2.2. 2-Hydroxy-benzophenones, </paragraph>
<paragraph id="P-0168" lvl="7"><number>&lsqb;0168&rsqb;</number> for example, the 4-hydroxy-, 4-methoxy-, 4-octoxy, 4-decyloxy-, 4-dodecyloxy-, 4-benzyloxy, 4,2&prime;,4&prime;-trihydroxy- and 2&prime;-hydroxy-4,4&prime;-dimethoxy derivatives. </paragraph>
<paragraph id="P-0169" lvl="7"><number>&lsqb;0169&rsqb;</number> 2.3. Esters of Optionally Substituted Benzoic Acids </paragraph>
<paragraph id="P-0170" lvl="7"><number>&lsqb;0170&rsqb;</number> for example, phenyl salicylate, 4-tert-butylphenyl salicylate, octylphenyl salicylate, dibenzoylresorcinol, bis-(4-tert-butylbenzoyl)-resorcinol, benzoylresorcinol, 3,5-di-tert-butyl-4-hydroxybenzoic acid 2,4-di-tert-butylphenyl ester and 3,5-di-tert-butyl-4-hydroxybenzoic acid hexadecyl ester. </paragraph>
<paragraph id="P-0171" lvl="7"><number>&lsqb;0171&rsqb;</number> 2.4. Acrylates, </paragraph>
<paragraph id="P-0172" lvl="7"><number>&lsqb;0172&rsqb;</number> for example, &agr;-cyano-&bgr;,&bgr;-diphenylacrylic acid ethyl ester or isooctyl ester, &agr;-carbomethoxy-cinnamic acid methyl ester, &agr;-cyano-&bgr;-methyl-p-methoxy-cinnamic acid methyl ester or butyl ester, &agr;-carbomethoxy-p-methoxy-cinnamic acid methyl ester, N-(&bgr;-carbomethoxy-&bgr;-cyanovinyl)-2-methyl-indoline. </paragraph>
<paragraph id="P-0173" lvl="7"><number>&lsqb;0173&rsqb;</number> 2.5. Nickel Compounds, </paragraph>
<paragraph id="P-0174" lvl="7"><number>&lsqb;0174&rsqb;</number> for example, nickel complexes of 2,2&prime;-thio-bis-&lsqb;4-(1,1,3,3-tetramethylbutyl)-phenol&rsqb;, such as the 1:1 or 1:2 complex, optionally with additional ligands such as n-butylamine, triethanolamine or N-cyclohexyl-diethanolamine, nickel dibutyldithiocarbamate, nickel salts of 4-hydroxy-3,5-di-tert-butylbenzylphosphonic acid monoalkyl esters, such as of the methyl, ethyl or butyl ester, nickel complexes of ketoximes such as of 2-hydroxy-4-methyl-phenyl undecyl ketoxime, nickel complexes of 1-phenyl-4-lauroyl-5-hydroxy-pyrazole, optionally with additional ligands. </paragraph>
<paragraph id="P-0175" lvl="7"><number>&lsqb;0175&rsqb;</number> 2.6. Sterically Hindered Amines, </paragraph>
<paragraph id="P-0176" lvl="7"><number>&lsqb;0176&rsqb;</number> for example bis-(2,2,6,6-tetramethylpiperidyl) sebacate, bis-(1,2,2,6,6-pentamethylpiperidyl) sebacate, n-butyl-3,5-di-tert.butyl-4-hydroxybenzyl malonic acid bis-(1,2,2,6,6-pentanemethylpiperidyl)ester, condensation product of 1-hydroxyethyl-2,2,6,6-tetramethyl-4-hydroxypiperidine and succinic acid, condensation product of N,N&prime;-(2,2,6,6-tetra-methylpiperidyl)-hexamethylenediamine and 4-tert-octylamino-2,6-dichloro-s-triazine, tris-(2,2,6,6-tetramethylpiperidyl)-nitrilotriacetate, tetrakis-(2,2,6,6-tetramethyl-4-piperidyl) 1,2,3,4-butanetetracarboxylate, 1,1&prime;(1,2-ethanediyl)-bis-(3,3,5,5-tetramethylpiperazinone), bis(1-octyloxy-2,2,6,6-tetramethylpiperidin-4-yl) sebacate. </paragraph>
<paragraph id="P-0177" lvl="7"><number>&lsqb;0177&rsqb;</number> 2.7. Oxalic Acid Diamides, </paragraph>
<paragraph id="P-0178" lvl="7"><number>&lsqb;0178&rsqb;</number> for example, 4,4&prime;-di-octyloxy-oxanilide, 2,2&prime;-di-octyloxy-5,5&prime;-di-tert-butyl-oxanilide, 2,2&prime;-di-dodecyloxy-5,5&prime;-di-tert-butyl-oxanilide, 2-ethoxy-2&prime;-ethyl-oxanilide, N,N&prime;-bis (3-dimethylaminopropyl)-oxalamide, 2-ethoxy-5-tert-butyl-2&prime;-ethyloxanilide and its mixture with 2-ethoxy-2&prime;-ethyl-5,4&prime;-di-tert-butyloxanilide and mixtures of ortho- and para-methoxy- as well as of o- and p-ethoxy-disubstituted oxanilides. </paragraph>
<paragraph id="P-0179" lvl="7"><number>&lsqb;0179&rsqb;</number> 2.8. Hydroxyphenyl-s-triazines, </paragraph>
<paragraph id="P-0180" lvl="7"><number>&lsqb;0180&rsqb;</number> for example 2,6-bis-(2,4-dimethylphenyl)-4-(2-hydroxy-4-octyloxyphenyl)-s-triazine; 2,6-bis-(2,4-dimethylphenyl)-4-(2,4-dihydroxyphenyl)-s-triazine; 2,4-bis(2,4-dihydroxyphenyl)-6-(4-chlorophenyl)-s-triazine; 2,4-bis&lsqb;2-hydroxy-4-(2-hydroxy-ethoxy)phenyl&rsqb;-6-(4-chlorophenyl)-s-triazine; 2,4-bis&lsqb;2-hydroxy-4-(2-hydroxy-4-(2-hydroxy-ethoxy)phenyl&rsqb;-6-(2,4-dimethylphenyl)-s-triazine; 2,4-bis&lsqb;2-hydroxy-4-(2-hydroxyethoxy)-phenyl&rsqb;-6-(4-bromophenyl)-s-triazine; 2,4-bis&lsqb;2-hydroxy-4-(2-acetoxyethoxy)phenyl&rsqb;-6-(4-chloro-phenyl)-s-triazine, 2,4-bis(2,4-dihydroxyphenyl)-6-(2,4-dimethylphenyl)-s-triazine. </paragraph>
<paragraph id="P-0181" lvl="7"><number>&lsqb;0181&rsqb;</number> 3. Metal Deactivators, </paragraph>
<paragraph id="P-0182" lvl="7"><number>&lsqb;0182&rsqb;</number> for example, N,N&prime;-diphenyloxalic acid diamide, N-salicylal-N&prime;-salicyloyl-hydrazine, N,N&prime;-bis-salicyloylhydrazine, N,N&prime;-bis-(3,5-di-tert-butyl-4-hydroxyphenylpropionyl)-hydrazine, 3-salicyloylamino-1,2,4-triazole, bis-benzylidene-oxalic acid dihydrazide. </paragraph>
<paragraph id="P-0183" lvl="7"><number>&lsqb;0183&rsqb;</number> 4. Phosphites and Phosphonites, </paragraph>
<paragraph id="P-0184" lvl="7"><number>&lsqb;0184&rsqb;</number> for example, triphenyl phosphite, diphenylalkyl phosphites, phenyldialkyl phosphites, tri-(nonylphenyl) phosphite, trilauryl phosphite, trioctadecyl phosphite, di-stearyl-pentaerythritol diphosphite, tris-(2,4-di-tert-butylphenyl) phosphite, di-isodecyl-pentaerythritol diphosphite, di-(2,4,6-tri-tert-butylphenyl)-pentaerythritol diphosphite, di-(2,4-di-tert-butyl-6-methylphenyl)-pentaerythritol diphosphite, di-(2,4-di-tert-butylphenyl)pentaerythritol diphosphite, tristearyl-sorbitol triphosphite, tetrakis-(2,4-di-tert-butylphenyl) 4,4&prime;-diphenylylenediphosphonite. </paragraph>
<paragraph id="P-0185" lvl="7"><number>&lsqb;0185&rsqb;</number> 5. Compounds which Destroy Peroxide, </paragraph>
<paragraph id="P-0186" lvl="7"><number>&lsqb;0186&rsqb;</number> for example, esters of &bgr;-thiodipropionic acid, for example the lauryl, stearyl, myristyl or tridecyl esters, mercapto-benzimidazole or the zinc salt of 2-mercaptobenzimidazole, zinc dibutyl-dithiocarbamate, dioctadecyl disulfide, pentaerythritol tetrakis-(&bgr;-dodecylmercapto)-propionate. </paragraph>
<paragraph id="P-0187" lvl="7"><number>&lsqb;0187&rsqb;</number> 6. Hydroxylamines, </paragraph>
<paragraph id="P-0188" lvl="7"><number>&lsqb;0188&rsqb;</number> for example, N,N-dibenzylhydroxylamine, N,N-diethylhydroxylamine, N,N-dioctylhydroxylamine, N,N-dilaurylhydroxylamine, N,N-ditetradecylhydroxylamine, N,N-dihexadecylhydroxylamine, N,N-dioctadecylhydroxylamine, N-hexadecyl-N-octadecylhydroxylamine, N-heptadecyl-N-octadecylhydroxylamine, N,N-dialkylhydroxylamine derived from hydrogenated tallow amine. </paragraph>
<paragraph id="P-0189" lvl="7"><number>&lsqb;0189&rsqb;</number> 7. Nitrones, </paragraph>
<paragraph id="P-0190" lvl="7"><number>&lsqb;0190&rsqb;</number> for example, N-benzyl-alpha-phenyl nitrone, N-ethyl-alpha-methyl nitrone, N-octyl-alpha-heptyl nitrone, N-lauryl-alpha-undecyl nitrone, N-tetradecyl-alpha-tridecyl nitrone, N-hexadecyl-alpha-pentadecyl nitrone, N-octadecyl-alpha-heptadecylnitrone, N-hexadecyl-alpha-heptadecyl nitrone, N-octadecyl-alpha-pentadecyl nitrone, N-heptadecyl-alpha-heptadecyl nitrone, N-octadecyl-alpha-hexadecyl nitrone, nitrone derived from N,N-dialkylhydroxylamine derived from hydrogenated tallow amine. </paragraph>
<paragraph id="P-0191" lvl="7"><number>&lsqb;0191&rsqb;</number> 8. Amine Oxides, </paragraph>
<paragraph id="P-0192" lvl="7"><number>&lsqb;0192&rsqb;</number> for example, tridecyl amine oxide, tridodecyl amine oxide, trihexadecyl amine oxide, tri(C<highlight><subscript>12</subscript></highlight>-C<highlight><subscript>14 </subscript></highlight>alkyl) amine oxide, tri(C<highlight><subscript>16</subscript></highlight>-C<highlight><subscript>18 </subscript></highlight>alkyl) amine oxide, tri(C<highlight><subscript>20</subscript></highlight>-C<highlight><subscript>22 </subscript></highlight>alkyl) amine oxide, di(C<highlight><subscript>12</subscript></highlight>-C<highlight><subscript>14 </subscript></highlight>alkyl) methyl amine oxide, di(C<highlight><subscript>16</subscript></highlight>-C<highlight><subscript>18 </subscript></highlight>alkyl) methyl amine oxide, di(C<highlight><subscript>20</subscript></highlight>-C<highlight><subscript>22 </subscript></highlight>alkyl) methyl amine oxide, di(tallow alkyl) methyl amine oxide, di(coco alkyl) methyl amine oxide. </paragraph>
<paragraph id="P-0193" lvl="7"><number>&lsqb;0193&rsqb;</number> 9. Polyamide Stabilizers, </paragraph>
<paragraph id="P-0194" lvl="7"><number>&lsqb;0194&rsqb;</number> for example copper salts in combination with iodides and/or phosphorus compounds and salts of divalent manganese. </paragraph>
<paragraph id="P-0195" lvl="7"><number>&lsqb;0195&rsqb;</number> 10. Basic Co-Stabilizers, </paragraph>
<paragraph id="P-0196" lvl="7"><number>&lsqb;0196&rsqb;</number> for example, melamine, polyinylpyrrolidone, dicyandiamide, triallyl cyanurate, urea derivatives, hydrazine derivatives, amines, polyamides, polyurethanes, alkali metal salts and alkaline earth metal salts of higher fatty acids for example Ca stearate, Zn stearate, Mg stearate, Na ricinoleate and K palmitate, antimony pyrocatecholate or zinc pyrocatecholate. </paragraph>
<paragraph id="P-0197" lvl="7"><number>&lsqb;0197&rsqb;</number> 11. Nucleating Agents, </paragraph>
<paragraph id="P-0198" lvl="7"><number>&lsqb;0198&rsqb;</number> for example, 4-tert-butyl-benzoic acid, adipic acid, diphenylacetic acid. </paragraph>
<paragraph id="P-0199" lvl="7"><number>&lsqb;0199&rsqb;</number> 12. Fillers and Reinforcing Agents, </paragraph>
<paragraph id="P-0200" lvl="7"><number>&lsqb;0200&rsqb;</number> for example, calcium carbonate, silicates, glass fibers, asbestos, talc, kaolin, mica, barium sulfate, metal oxides and hydroxides, carbon black, graphite. </paragraph>
<paragraph id="P-0201" lvl="7"><number>&lsqb;0201&rsqb;</number> 13. Other additives, for example, plasticizers, lubricants, emulsifiers, pigments, optical brighteners, flameproofing agents, anti-static agents, blowing agents and thiosynergists such as dilauryl thiodipropionate or distearyl thiodipropionate. </paragraph>
<paragraph id="P-0202" lvl="7"><number>&lsqb;0202&rsqb;</number> 14. Benzofuranones and Indolinones, </paragraph>
<paragraph id="P-0203" lvl="7"><number>&lsqb;0203&rsqb;</number> for example those disclosed in U.S. Pat. Nos. 4,325,863, 4,338,244 or 5,175,312, or 3-&lsqb;4-(2-acetoxyethoxy)phenyl&rsqb;-5,7-di-tert-butyl-benzofuran-2-one, 5,7-di-tert-butyl-3-&lsqb;4-(2-stearoyloxyethoxy)phenyl&rsqb;benzofuran-2-one, 3,3&prime;-bis&lsqb;5,7-di-tert-butyl-3-(4-&lsqb;2-hydroxyethoxy&rsqb;phenyl)benzofuran-2-one&rsqb;, 5,7-di-tert-butyl-3-(4-ethoxyphenyl)-benzofuran-2-one, 3-(4-acetoxy-3,5-dimethylphenyl)-5,7-di-tert-butyl-benzofuran-2-one, 3-(3,5-di-methyl-4-pivaloyloxyphenyl)-5,7-di-tert-butyl-benzofuran-2-one. </paragraph>
<paragraph id="P-0204" lvl="0"><number>&lsqb;0204&rsqb;</number> The co-stabilizers, with the exception of the benzofuranones listed under 14, are added for example in concentrations of 0.01 to 10%, relative to the total weight of the material to be stabilized. </paragraph>
<paragraph id="P-0205" lvl="0"><number>&lsqb;0205&rsqb;</number> Further preferred compositions comprise, in addition to components (a) and (b) further additives, in particular phenolic antioxidants, light stabilizers or processing stabilizers. </paragraph>
<paragraph id="P-0206" lvl="0"><number>&lsqb;0206&rsqb;</number> Particularly preferred additives are phenolic antioxidants (item 1 of the list), sterically hindered amines (item 2.6 of the list), phosphites and phosphonites (item 4 of the list), UV absorbers (item 2 of the list) and peroxide-destroying compounds (item 5 of the list). </paragraph>
<paragraph id="P-0207" lvl="0"><number>&lsqb;0207&rsqb;</number> Additional additives (stabilizers) which are also particularly preferred are benzofuran-2-ones, such as described, for example, in U.S. Pat. Nos. 4,325,863, 4,338,244 or 5,175,312. </paragraph>
<paragraph id="P-0208" lvl="0"><number>&lsqb;0208&rsqb;</number> The phenolic antioxidant of particular interest is selected from the group consisting of n-octadecyl 3,5-di-tert-butyl-4-hydroxyhydrocinnamate, neopentanetetrayl tetrakis(3,5-di-tert-butyl-4-hydroxyhydrocinammate), di-n-octadecyl 3,5-di-tert-butyl-4-hydroxybenzylphosphonate, 1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)isocyanurate, thiodiethylene bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate), 1,3,5-trimethyl-2,4,6-tris(3,5-di-tert-butyl-4-hydroxy-benzyl)benzene, 3,6-dioxaoctamethylene bis(3-methyl-5-tert-butyl-4-hydroxyhydrocinnamate), 2,6-di-tert-butyl-p-cresol, 2,2&prime;-ethylidene-bis(4,6-di-tert-butylphenol), 1,3,5-tris(2,6-dimethyl-4-tert-butyl-3-hydroxybenzyl)isocyanurate, 1,1,3,-tris(2-methyl-4-hydroxy-5-tert-butylphenyl)butane, 1,3,5-tris &lsqb;2-(3,5-di-tert-butyl-4-hydroxyhydrocinnamoyloxy)ethyl&rsqb;isocyanurate, 3,5-di-(3,5-di-tert-butyl-4-hydroxybenzyl)mesitol, hexamethylene bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate), 1-(3,5-di-tert-butyl-4-hydroxyanilino)-3,5-di(octylthio)-s-triazine, N,N&prime;-hexamethylene-bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamamide), calcium bis(ethyl 3,5-di-tert-butyl-4-hydroxybenzylphosphonate), ethylene bis&lsqb;3,3-di(3-tert-butyl-4-hydroxyphenyl)butyrate&rsqb;, octyl 3,5-di-tert-butyl-4-hydroxybenzylmercaptoacetate, bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamoyl)hydrazide, and N,N&prime;-bis&lsqb;2-(3,5-di-tert-butyl-4-hydroxyhydrocinnamoyloxy)-ethyl&rsqb;-oxamide. </paragraph>
<paragraph id="P-0209" lvl="0"><number>&lsqb;0209&rsqb;</number> A most preferred phenolic antioxidant is neopentanetetrayl tetrakis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate), n-octadecyl 3,5-di-tert-butyl-4-hydroxyhydrocinnamate, 1,3,5-tri-methyl-2,4,6-tris(3,5-di-tert-butyl-4-hydroxybenzyl)benzene, 1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)isocyanurate, 2,6-di-tert-butyl-p-cresol or 2,2&prime;-ethylidene-bis(4,6-di-tert-butylphenol). </paragraph>
<paragraph id="P-0210" lvl="0"><number>&lsqb;0210&rsqb;</number> The hindered amine compound of particular interest is selected from the group consisting of </paragraph>
<paragraph id="P-0211" lvl="1"><number>&lsqb;0211&rsqb;</number> bis(2,2,6,6-tetramethylpiperidin-4-yl) sebacate, </paragraph>
<paragraph id="P-0212" lvl="1"><number>&lsqb;0212&rsqb;</number> bis(1,2,2,6,6-pentamethylpiperidin-4-yl) sebacate, </paragraph>
<paragraph id="P-0213" lvl="1"><number>&lsqb;0213&rsqb;</number> di(1,2,2,6,6-pentamethylpiperidin-4-yl) (3,5-di-tert-butyl-4-hydroxybenzyl)butylmalonate, </paragraph>
<paragraph id="P-0214" lvl="1"><number>&lsqb;0214&rsqb;</number> 4-benzoyl-2,2,6,6-tetramethylpiperidine, 4-stearyloxy-2,2,6,6-tetramethylpiperidine, </paragraph>
<paragraph id="P-0215" lvl="1"><number>&lsqb;0215&rsqb;</number> 3-n-octyl-7,7,9,9-tetramethyl-1,3,8-triaza-spiro&lsqb;4.5&rsqb;decane-2,4-dione, tris(2,2,6,6-tetramethylpiperidin-4-yl) nitrilotriacetate, </paragraph>
<paragraph id="P-0216" lvl="1"><number>&lsqb;0216&rsqb;</number> 1,2-bis(2,2,6,6-tetramethyl-3-oxopiperazin-4-yl)ethane, 2,2,4,4-tetramethyl-7-oxa-3,20-diaza-21-oxodispiro&lsqb;5.1.11.2&rsqb;heneicosane, polycondensation product of 2,4-dichloro-6-tert-octylamino-s-triazine and 4,4&prime;-hexamethylenebis(amino-2,2,6,6-tetramethylpiperidine), </paragraph>
<paragraph id="P-0217" lvl="1"><number>&lsqb;0217&rsqb;</number> polycondensation product of 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-hydroxypiperidine and succinic acid, polycondensation product of 4,4&prime;-hexamethylenebis-(amino-2,2,6,6-tetra-methylpiperidine) and 1,2-dibromoethane, </paragraph>
<paragraph id="P-0218" lvl="1"><number>&lsqb;0218&rsqb;</number> tetrakis(2,2,6,6-tetramethylpiperidin-4-yl) 1,2,3,4-butanetetracarboxylate, </paragraph>
<paragraph id="P-0219" lvl="1"><number>&lsqb;0219&rsqb;</number> tetrakis(1,2,2,6,6-pentamethylpiperidin-4-yl) 1,2,3,4-butanetetracarboxylate, </paragraph>
<paragraph id="P-0220" lvl="1"><number>&lsqb;0220&rsqb;</number> polycondensation product of 2,4-dichloro-6-morpholino-s-triazine and </paragraph>
<paragraph id="P-0221" lvl="1"><number>&lsqb;0221&rsqb;</number> 4,4&prime;-hexamethylenebis(amino-2,2,6,6-tetramethylpiperidine), N,N&prime;,N&Prime;,N&prime;&Prime;-tetrakis&lsqb;(4,6-bis(butyl-1,2,2,6,6-pentamethyl-piperidin-4-yl)-amino-s-triazin-2-yl&rsqb;-1,10-diamino-4,7-diazadecane, mixed </paragraph>
<paragraph id="P-0222" lvl="1"><number>&lsqb;0222&rsqb;</number> &lsqb;2,2,6,6-tetramethylpiperidin-4-yl/&bgr;,&bgr;,&bgr;&prime;,&bgr;&prime;-tetramethyl-3,9-(2,4,8,10-tetraoxaspiro&lsqb;5.5&rsqb;-undecane) diethyl&rsqb; 1,2,3,4-butanetetracarboxylate, </paragraph>
<paragraph id="P-0223" lvl="1"><number>&lsqb;0223&rsqb;</number> mixed &lsqb;1,2,2,6,6-pentamethylpiperidin-4-yl/&bgr;,&bgr;,&bgr;&prime;,&bgr;&prime;-tetramethyl-3,9-(2,4,8,10-tetraoxaspiro&lsqb;5.5&rsqb;-undecane)diethyl&rsqb; 1,2,3,4-butanetetracarboxylate, octamethylene bis(2,2,6,6-tetramethyl-piperidin-4-carboxylate), </paragraph>
<paragraph id="P-0224" lvl="1"><number>&lsqb;0224&rsqb;</number> 4,4&prime;-ethylenebis(2,2,6,6-tetramethylpiperazin-3-one), N-2,2,6,6-tetramethyl-piperidin-4-yl-n-dodecylsuccinimide, N-1,2,2,6,6-pentamethyl-piperidin-4-yl-n-dodecylsuccinimide, N-1-acetyl-2,2,6,6-tetramethylpiperidin-4-yln-dodecylsuccinimide, 1-acetyl3-dodecyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro&lsqb;4.5&rsqb;decane-2,4-dione, </paragraph>
<paragraph id="P-0225" lvl="1"><number>&lsqb;0225&rsqb;</number> di-(1-octyloxy-2,2,6,6-tetramethylpiperidin-4-yl) sebacate, di- (1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl) succinate, 1-octyloxy-2,2,6,6-tetramethyl-4-hydroxy-piperidine, </paragraph>
<paragraph id="P-0226" lvl="1"><number>&lsqb;0226&rsqb;</number> poly-&lcub;&lsqb;6-tert-octylamino-s-triazin-2,4-diyl&rsqb; &lsqb;2-(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl)imino-hexamethylene-&lsqb;4-(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl)imino&rsqb;, and </paragraph>
<paragraph id="P-0227" lvl="1"><number>&lsqb;0227&rsqb;</number> 2,4,6-tris&lsqb;N-(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl)-n-butylamino&rsqb;-s-triazine. </paragraph>
<paragraph id="P-0228" lvl="0"><number>&lsqb;0228&rsqb;</number> A most preferred hindered amine compound is bis(2,2,6,6-tetramethylpiperidin-4-yl) sebacate, bis(1,2,2,6,6-pentamethylpiperidin-4-yl) sebacate, di(1,2,2,6,6-pentamethylpiperidin-4-yl) (3,5-di-tert-butyl-4-hydroxybenzyl)butylmalonate, the polycondensation product of 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-hydroxypiperidine and succinic acid, the polycondensation product of 2,4-dichloro-6-tert-octylamino-s-triazine and 4,4&prime;-hexamethylenebis(amino-2,2,6,6-tetramethylpiperidine), N,N&prime;,N&Prime;,N&prime;&Prime;-tetrakis&lsqb;(4,6-bis(butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino)-s-triazine-2-yl&rsqb;-1,10-diamino-4,7-diazadecane. di-(1-octyloxy-2,2,6,6-tetramethylpiperidin-4-yl) sebacate, di-(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl) succinate, 1-octyloxy-2,2,6,6-tetramethyl-4-hydroxy-piperidine, poly-&lcub;&lsqb;6-tert-octylamino-s-triazin-2,4-diyl&rsqb; &lsqb;2-(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl)imino-hexamethylene-&lsqb;4-(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl)imino&rsqb;, or 2,4,6-tris&lsqb;N-(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl)-n-butylamino&rsqb;-s-triazine. </paragraph>
<paragraph id="P-0229" lvl="0"><number>&lsqb;0229&rsqb;</number> The instant composition can additionally contain another UV absorber selected from the group consisting of the benzotriazoles, s-triazines, the oxanilides, the hydroxybenzophenones, benzoates and the &agr;-cyanoacrylates. </paragraph>
<paragraph id="P-0230" lvl="0"><number>&lsqb;0230&rsqb;</number> The instant composition may additionally contain an effective stabilizing amount of at least one other 2-hydroxyphenyl-2H-benzotriazole; another tris-aryl-s-triazine; or hindered amine or mixtures thereof. </paragraph>
<paragraph id="P-0231" lvl="0"><number>&lsqb;0231&rsqb;</number> For example, the <highlight><superscript>2</superscript></highlight>-hydroxyphenyl-2H-benzotriazole is selected from the group consisting of </paragraph>
<paragraph id="P-0232" lvl="2"><number>&lsqb;0232&rsqb;</number> 2-(2-hydroxy-3,5-di-tert-amylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0233" lvl="2"><number>&lsqb;0233&rsqb;</number> 2-&lsqb;2-hydroxy-3,5-di(&agr;,&agr;-dimethylbenzyl)phenyl&rsqb;-2H-benzotriazole; </paragraph>
<paragraph id="P-0234" lvl="2"><number>&lsqb;0234&rsqb;</number> 2-&lsqb;2-hydroxy-3-(&agr;,&agr;-dimethylbenzyl)-5-tert-octylphenyl&rsqb;-2H-benzotriazole; </paragraph>
<paragraph id="P-0235" lvl="2"><number>&lsqb;0235&rsqb;</number> 2-&lcub;2-hydroxy-3-tert-butyl-5-&lsqb;2-(omega-hydroxy-octa(ethyleneoxy)carbonyl)ethyl&rsqb;-phenyl&rcub;-2H-benzotriazole; </paragraph>
<paragraph id="P-0236" lvl="2"><number>&lsqb;0236&rsqb;</number> 5-chloro-2-(2-hydroxy-3,5-di-tert-butylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0237" lvl="2"><number>&lsqb;0237&rsqb;</number> 5-chloro-2-(2-hydroxy-3-tert-butyl-5-methylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0238" lvl="2"><number>&lsqb;0238&rsqb;</number> 2-(2-hydroxy-5-tert-octylphenyl)-2H-benzotriazole; and </paragraph>
<paragraph id="P-0239" lvl="2"><number>&lsqb;0239&rsqb;</number> 2-&lcub;2-hydroxy-3-tert-butyl-5-&lsqb;2-(octyloxy)carbonyl)ethyl&rsqb;phenyl&rcub;-2H-benzotriazole. </paragraph>
<paragraph id="P-0240" lvl="0"><number>&lsqb;0240&rsqb;</number> In another embodiment, the tris-aryl-s-triazine is selected from the group consisting of </paragraph>
<paragraph id="P-0241" lvl="2"><number>&lsqb;0241&rsqb;</number> 2,4-bis(2,4-dimethylphenyl)-6-(2-hydroxy-4-octyloxyphenyl)-s-triazine; </paragraph>
<paragraph id="P-0242" lvl="2"><number>&lsqb;0242&rsqb;</number> 2,4-diphenyl-6-(2-hydroxy-4-hexyloxyphenyl)-s-triazine; </paragraph>
<paragraph id="P-0243" lvl="1"><number>&lsqb;0243&rsqb;</number> 2,4-bis(2,4-dimethylphenyl)-6-&lsqb;2-hydroxy-4-(3-do-/tri-decyloxy-2-hydroxypropoxy)-phenyl&rsqb;-s-triazine; and </paragraph>
<paragraph id="P-0244" lvl="2"><number>&lsqb;0244&rsqb;</number> 2-(2-hydroxyethylamino)-4,6-bis &lsqb;N-butyl-N-(1-cyclohexyloxy-2,2,6,6-tetramethyl-piperidin-4-yl)amino&rsqb;-s-triazine. </paragraph>
<paragraph id="P-0245" lvl="0"><number>&lsqb;0245&rsqb;</number> The alkyd resin lacquers which can be stabilized against the action of light and moisture in accordance with the instant invention are the conventional stoving lacquers which are used in particular for coating automobiles (automobile finishing lacquers), for example lacquers based on alkyd/melamine resins and alkyd/acrylic/melamine resins (see H. Wagner and H. F. Sarx, &ldquo;Lackkunstharze&rdquo; (1977), pages 99-123). Other crosslinking agents include glycouril resins, blocked isocyanates or epoxy resins. </paragraph>
<paragraph id="P-0246" lvl="0"><number>&lsqb;0246&rsqb;</number> The lacquers stabilized in accordance with the invention are suitable both for metal finish coatings and solid shade finishes, especially in the case of retouching finishes, as well as various coil coating applications. The lacquers stabilized in accordance with the invention are preferably applied in the conventional manner by two methods, either by the single-coat method or by the two-coat method. In the latter method, the pigment-containing base coat is applied first and then a covering coat of clear lacquer over it. </paragraph>
<paragraph id="P-0247" lvl="0"><number>&lsqb;0247&rsqb;</number> It is also to be noted that the compounds of the present invention are applicable for use in non-acid catalyzed thermoset resins such as epoxy, epoxy-polyester, vinyl, alkyd, acrylic and polyester resins, optionally modified with silicon, isocyanates or isocyanurates. The epoxy and epoxy-polyester resins are crosslinked with conventional cross-linkers such as acids, acid anhydrides, amines and the like. Correspondingly, the epoxide may be utilized as the crosslinking agent for various acrylic or polyester resin systems that have been modified by the presence of reactive groups on the backbone structure. </paragraph>
<paragraph id="P-0248" lvl="0"><number>&lsqb;0248&rsqb;</number> When used in two-coat finishes, the compounds of the instant invention can be incorporated in the clear coat or both in the clear coat and in the pigmented base coat. </paragraph>
<paragraph id="P-0249" lvl="0"><number>&lsqb;0249&rsqb;</number> When water-soluble, water miscible or water dispersible coating are desired ammonium salts of acid groups present in the resin are formed. Powder coating composition can be prepared by reacting glycidyl methacrylate with selected alcohol components. </paragraph>
<paragraph id="P-0250" lvl="0"><number>&lsqb;0250&rsqb;</number> The instant benzotriazoles are made by conventional methods for preparing such compounds. The usual procedure involves the diazotization of a substituted o-nitroaniline followed by coupling the resultant diazonium salt with a substituted phenol and reduction of the azobenzene intermediate to the corresponding desired benzotriazole. The starting materials for these benzotriazoles are largely items of commerce or can be prepared by normal methods of organic synthesis. </paragraph>
<paragraph id="P-0251" lvl="0"><number>&lsqb;0251&rsqb;</number> While the instant benzotriazoles with their enhanced durability are particularly suited for automotive coating applications, it is contemplated that they will also be espeically useful in other applications where their enhanced durability is required such as in solar films and the like. </paragraph>
<paragraph id="P-0252" lvl="0"><number>&lsqb;0252&rsqb;</number> The compounds of Examples 4 and 6, namely the cis and trans isomers of 1-(2,3-dihydrobenzofuran-3-ylmethoxy)-2,2,6,6-tetramethylpiperidine and 1-(3-phenyl-2,3-dihydrobenzofuran-3-ylmethoxy)-2,2,6,6-tetramethylpiperidine, are novel. </paragraph>
<paragraph id="P-0253" lvl="0"><number>&lsqb;0253&rsqb;</number> Still another embodiment of the instant invention is a composition which comprises </paragraph>
<paragraph id="P-0254" lvl="2"><number>&lsqb;0254&rsqb;</number> (a) candle wax which is white and scented, white and unscented, dyed and scented, dyed and unscented, dipped and scented or dipped and unscented, and </paragraph>
<paragraph id="P-0255" lvl="2"><number>&lsqb;0255&rsqb;</number> (b) an effective stabilizing amount of a compound of formula I, II or III as described above. </paragraph>
<paragraph id="P-0256" lvl="0"><number>&lsqb;0256&rsqb;</number> It should be noted that candles contain a host of various components. The base materials may be made up of the following: </paragraph>
<paragraph id="P-0257" lvl="2"><number>&lsqb;0257&rsqb;</number> paraffin wax, </paragraph>
<paragraph id="P-0258" lvl="2"><number>&lsqb;0258&rsqb;</number> natural oils, </paragraph>
<paragraph id="P-0259" lvl="2"><number>&lsqb;0259&rsqb;</number> polyamide plus fatty acid/ester, </paragraph>
<paragraph id="P-0260" lvl="2"><number>&lsqb;0260&rsqb;</number> fatty acids such as stearin, </paragraph>
<paragraph id="P-0261" lvl="2"><number>&lsqb;0261&rsqb;</number> opacifiers, </paragraph>
<paragraph id="P-0262" lvl="2"><number>&lsqb;0262&rsqb;</number> beeswax, </paragraph>
<paragraph id="P-0263" lvl="2"><number>&lsqb;0263&rsqb;</number> glycerides plus oxidized wax, </paragraph>
<paragraph id="P-0264" lvl="2"><number>&lsqb;0264&rsqb;</number> alcohols, and </paragraph>
<paragraph id="P-0265" lvl="2"><number>&lsqb;0265&rsqb;</number> ethylene oligomers. </paragraph>
<paragraph id="P-0266" lvl="0"><number>&lsqb;0266&rsqb;</number> Candles also contain a number of additives such as the following: </paragraph>
<paragraph id="P-0267" lvl="2"><number>&lsqb;0267&rsqb;</number> mold release agents, </paragraph>
<paragraph id="P-0268" lvl="2"><number>&lsqb;0268&rsqb;</number> fragrances, </paragraph>
<paragraph id="P-0269" lvl="2"><number>&lsqb;0269&rsqb;</number> insect repellants or insecticides, </paragraph>
<paragraph id="P-0270" lvl="2"><number>&lsqb;0270&rsqb;</number> hardeners, </paragraph>
<paragraph id="P-0271" lvl="2"><number>&lsqb;0271&rsqb;</number> crystal modifiers, </paragraph>
<paragraph id="P-0272" lvl="2"><number>&lsqb;0272&rsqb;</number> clarifiers, </paragraph>
<paragraph id="P-0273" lvl="2"><number>&lsqb;0273&rsqb;</number> guttering reducers, </paragraph>
<paragraph id="P-0274" lvl="2"><number>&lsqb;0274&rsqb;</number> colorants, </paragraph>
<paragraph id="P-0275" lvl="2"><number>&lsqb;0275&rsqb;</number> f.p. control agents, </paragraph>
<paragraph id="P-0276" lvl="2"><number>&lsqb;0276&rsqb;</number> stretchability improvers, </paragraph>
<paragraph id="P-0277" lvl="2"><number>&lsqb;0277&rsqb;</number> gelling agents, </paragraph>
<paragraph id="P-0278" lvl="2"><number>&lsqb;0278&rsqb;</number> extrusion aids, and </paragraph>
<paragraph id="P-0279" lvl="2"><number>&lsqb;0279&rsqb;</number> vortex reducers. </paragraph>
<paragraph id="P-0280" lvl="0"><number>&lsqb;0280&rsqb;</number> Each of the various components are meant to control or modify the properties of the candle to insure proper burning, reduce channelling, aid in uniform melting, and the like. The colorants and fragrances obviously are there to provide the proper color, scent or other aesthetic appeal. </paragraph>
<paragraph id="P-0281" lvl="0"><number>&lsqb;0281&rsqb;</number> Of increasing importance are the transparent gel candles which look like clear glass, but which burn like a classical candle. As is discussed in detail in U.S. Pat. No. 5,879,694, the relevant parts of which are incorporated herein by reference, these gel candles usually contain a copolymer selected from the group consisting of a triblock, radial block, diblock or multiblock copolymer classically made up of at least two thermodynamically incompatible segments containing both hard and soft segments. Typical of such block copolymers is KRATON&reg; (Shell Chemical Co.) which consists of block segments of styrene monomer units and rubber monomer or comonomer units. The most common structure found in KRATON&reg; D series is a linear ABA block with styrene-butadiene-styrene (SBS) or styrene-isoprene-styrene (SIS). </paragraph>
<paragraph id="P-0282" lvl="0"><number>&lsqb;0282&rsqb;</number> The following examples are for illustrative purposes only and are not to be construed to limit the scope of the invention in any manner whatsoever. </paragraph>
</section>
</summary-of-invention>
<detailed-description>
<section>
<heading lvl="1">EXAMPLE 1 </heading>
</section>
<section>
<heading lvl="1">1-(2,3-Dihydrobenzofuran-3-ylmethoxy)-2,2,6,6-tetramethylpiperidine </heading>
<paragraph id="P-0283" lvl="0"><number>&lsqb;0283&rsqb;</number> To a solution of 1.95 g (12.5 mmol) of 1-oxyl-2,2,6,6-tetramethylpiperidine, 3.1 g (30 mmol) of tert-butyl nitrite and 7.5 mg (0.012 mmol) of (S,S)-(&plus;)-N,N-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II) in 100 mL of pyridine at 65&deg;-70&deg; C. under a nitrogen atmosphere is added dropwise over 20 minutes a solution of 5.6 g (25 mmol) of 2-allyloxyaniline in 20 mL of pyridine. The evolution of gas is observed during the addition of the 2-allyloxyaniline. After the addition is complete, the reaction mixture is kept at 65&deg;-70&deg; C. for an additional forty minutes until gas evolution subsided. After cooling to ambient temperature, the reaction mixture is then concentrated. The residue obtained is purified by vacuum flash chromatography (heptane) to give 2.3 g of a viscous liquid in 63.7% yield. The structure is confirmed by <highlight><superscript>1</superscript></highlight>Hnmr and elemental analyses. </paragraph>
<paragraph id="P-0284" lvl="7"><number>&lsqb;0284&rsqb;</number> <highlight><superscript>1</superscript></highlight>Hnmr (C<highlight><subscript>6</subscript></highlight>D<highlight><subscript>6</subscript></highlight>) (300.08 MHz) 1.15 (s, CH<highlight><subscript>3</subscript></highlight>, 6H), 1.45 (s, CH<highlight><subscript>3</subscript></highlight>, 6H), 1.64, 1.42, 1.29 (overlapping m, CH<highlight><subscript>2</subscript></highlight>, 6H), 3.71 (q, CH, 1H), 3.89 (dd, CH, 1H, <highlight><superscript>2</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;9.90 Hz, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&Prime;</subscript></highlight>&equals;7.65 Hz), 3.99 (dd, CH, <highlight><superscript>2</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;9.23 Hz, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&Prime;</subscript></highlight>&equals;7.43 Hz), 4.40 (dd, CH, 1H, <highlight><superscript>2</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;8.92 Hz, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&Prime;</subscript></highlight>&equals;6.59 Hz), 4.63 (dd, CH, 1H, <highlight><superscript>2</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;10.01 HZ, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&Prime;</subscript></highlight>&equals;8.93 Hz), 6.80 (d, 1H, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;6.87 Hz), 6.85 (t, 1H. <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;5.72 Hz), 7.14 (t, 1H, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;7.18 Hz), 7.25 (d, 1H, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;7.44 Hz). </paragraph>
<paragraph id="P-0285" lvl="7"><number>&lsqb;0285&rsqb;</number> Analysis:  
<table-cwu id="TABLE-US-00003">
<number>3</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="35PT" align="left"/>
<colspec colname="1" colwidth="70PT" align="right"/>
<colspec colname="2" colwidth="112PT" align="left"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
<entry>Calcd for C<highlight><subscript>18</subscript></highlight>H<highlight><subscript>27</subscript></highlight>NO<highlight><subscript>2</subscript></highlight>:</entry>
<entry>C, 74.7; H, 9.4; N, 4.8.</entry>
</row>
<row>
<entry></entry>
<entry>Found:</entry>
<entry>C, 74.5; H, 9.1; N, 4.9.</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 2 </heading>
</section>
<section>
<heading lvl="1">1-(2,3-Dihydrobenzofuran-3-ylmethoxy)-2,2,6,6-tetramethylpiperidine </heading>
<paragraph id="P-0286" lvl="0"><number>&lsqb;0286&rsqb;</number> The procedure of Example 1 is repeated using 1.95 g (12.5 mmol) of 1-oxyl-2,2,6,6-tetramethyl-4-hydroxypiperidine, 3.10 g (30 mmol) of tert-butyl nitrite, 7.5 mg (0.012 mmol) of (S,S)-(&plus;)-N,N-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II) mmol) in 100 mL of chlorobenzene and 5.60 g (25 mmol) of 2-allyloxyaniline in 20 mL of chlorobenzene. The crude product obtained is purified by vacuum flash chromatography (25% ethyl acetate/heptane) to give 2.22 g of a viscous liquid in 61.5% yield. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 3 </heading>
</section>
<section>
<heading lvl="1">1-(2,3-Dihydrobenzofuran-3-ylmethoxy)-2,2,6,6-tetramethylpiperidine </heading>
<paragraph id="P-0287" lvl="0"><number>&lsqb;0287&rsqb;</number> The procedure of Example 1 is repeated using 1.95 g (12.5 mmol) of 1-oxyl-2,2,6,6-tetramethyl-4-hydroxypiperidine, 3.10 g (30 mmol) of tert-butyl nitrite, 2.4 g (25 mmol) of pyridine, 7.5 mg (0.012 mmol) of (S,S)-(&plus;)-N,N-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II) mmol) in 100 mL of chlorobenzene and 5.60 g (25 mmol) of 2-allyloxyaniline in 20 mL of chlorobenzene. The crude product obtained is purified by vacuum flash chromatography (25% ethyl acetate/heptane) to give 2.13 g of a viscous liquid in 59.0% yield. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 4 </heading>
</section>
<section>
<heading lvl="1">The Cis and Trans Isomers of 1-(2,3-Dihydrobenzofuran-3-yl-methoxy)-2,2,6,6-tetramethylpiperidine </heading>
<paragraph id="P-0288" lvl="0"><number>&lsqb;0288&rsqb;</number> The procedure of Example 1 is repeated using 3.0 g (19 mmol) of 1-oxyl-2,2,6,6-tetramethyl-4-hydroxypiperidine, 4.64 g (45 mmol) of tert-butyl nitrite, 11.45 mg (0.019 mmol) of (S,S)-(&plus;)-N,N-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II) mmol) in 80 mL of pyridine and 6.27 g (38 mmol) of 2-(1-methylallyloxyaniline in 10 mL of pyridine. The crude product obtained is purified by vacuum flash chromatography (25% ethyl acetate/heptane) to give 5.31 g of a viscous liquid in 92.4% yield. The cis and trans isomers can be further separated by chromatography. The structures are confirmed by <highlight><superscript>1</superscript></highlight>Hnmr analysis. </paragraph>
<paragraph id="P-0289" lvl="7"><number>&lsqb;0289&rsqb;</number> <highlight><superscript>1</superscript></highlight>Hnmr (C<highlight><subscript>6</subscript></highlight>D<highlight><subscript>6</subscript></highlight>) (499.85 MHz): </paragraph>
<paragraph id="P-0290" lvl="1"><number>&lsqb;0290&rsqb;</number> trans isomer: 1.13 (d, CH<highlight><subscript>3</subscript></highlight>, 6H), 1.05 (s, CH<highlight><subscript>3</subscript></highlight>, 6H), 1.11 (s, CH<highlight><subscript>3</subscript></highlight>, 6H), 1.48 (overlapping m, CH<highlight><subscript>2</subscript></highlight>, 6H), 3.35 (dt, CH, 1H, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;9.34 Hz, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&Prime;</subscript></highlight>&equals;5.24 Hz), 4.01 (q, CH, 1H, <highlight><superscript>2</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;12.50 Hz, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&Prime;</subscript></highlight>&equals;6.44 Hz), 4.26 (t, CH, 1H, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;9.00 Hz), 4.40 (dd, CH, 1H, <highlight><superscript>2</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;9.09 Hz, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&Prime;</subscript></highlight>&equals;4.98 Hz), 6.82 (td, 1H, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;7.46 Hz, <highlight><superscript>4</superscript></highlight>J<highlight><subscript>HH&Prime;</subscript></highlight>&equals;1.02 Hz), 6.89 (d, 1H, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&Prime;</subscript></highlight>&equals;7.99 Hz), 7.02 (t, 1H, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;7.71 Hz), 7.29 (d, 1H, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;7.43 Hz). </paragraph>
<paragraph id="P-0291" lvl="7"><number>&lsqb;0291&rsqb;</number> cis isomer: 1.03 (d, CH<highlight><subscript>3</subscript></highlight>, 3H), 1.05 (s, CH<highlight><subscript>3</subscript></highlight>, 6H), 1.11 (s, CH<highlight><subscript>3</subscript></highlight>, 6H), 1.20 (overlapping m, CH<highlight><subscript>2</subscript></highlight>, 6H), 3.68 (dt, CH, 1H, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;9.11 Hz, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&Prime;</subscript></highlight>&equals;4.69 Hz), 4.15 (q, CH, 1H, <highlight><superscript>2</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;6.54 Hz, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&Prime;</subscript></highlight>&equals;4.90 Hz), 4.28 (t, CH, 1H, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;9.04 Hz), 4.51 (dd, CH, 1H, <highlight><superscript>2</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;9.11 Hz, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&Prime;</subscript></highlight>&equals;4.70 Hz), 6.77 (td, 1H, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;7.39 Hz, <highlight><superscript>4</superscript></highlight>J<highlight><subscript>HH&Prime;</subscript></highlight>&equals;0.99 Hz), 6.88 (d, 1H, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;7.81 Hz), 7.00 (t, 1H, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;7.92 Hz), 7.11 (d, 1H, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;7.40 Hz). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 5 </heading>
</section>
<section>
<heading lvl="1">N,N-Di-tert-butyl-O-(2,3-dihydrobenzofuran-3-ylmethyl)hydroxylamine </heading>
<paragraph id="P-0292" lvl="0"><number>&lsqb;0292&rsqb;</number> The procedure of Example 1 is repeated using 1.8 g (12.5 mmol) of di-tert-butyl nitroxide, 3.09 g (30 mmol) of tert-butyl nitrite, 7.6 mg (0.0125 mmol) of (S,S)-(&plus;)-N,N-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II) mmol) in 100 mL of pyridine and 5.62 g (25 mmol) of 2-allyloxyaniline in 10 mL of pyridine. The crude product obtained is purified by dry column flash chromatography (25% ethyl acetate/heptane) to give 2.43 g g of a viscous liquid in 85.9% yield. The structure is confirmed by <highlight><superscript>1</superscript></highlight>Hnmr and mass spectrographic analyses. </paragraph>
<paragraph id="P-0293" lvl="7"><number>&lsqb;0293&rsqb;</number> <highlight><superscript>1</superscript></highlight>Hnmr (C<highlight><subscript>6</subscript></highlight>D<highlight><subscript>6</subscript></highlight>) (300.08 MHz) 1.11 (s, CH<highlight><subscript>3</subscript></highlight>, 9H), 1.13 (s, CH<highlight><subscript>3</subscript></highlight>, 9H), 3.36 (q, CH, 1H), 3.73 (dd, CH, 1H, <highlight><superscript>2</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;9.09 Hz, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&Prime;</subscript></highlight>&equals;8.05 Hz), 3.86 (dd, CH, 1H, <highlight><superscript>2</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;8.90 Hz, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&Prime;</subscript></highlight>&equals;6.54 Hz), 4.40 (dd, CH, 1H, <highlight><superscript>2</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;8.99 Hz, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&Prime;</subscript></highlight>&equals;6.07 Hz), 4.63 (dd, CH, 1H, <highlight><superscript>2</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;9.00 Hz, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&Prime;</subscript></highlight>&equals;8.79 Hz), 6.73 (dt, 1H, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;7.41 Hz, <highlight><superscript>4</superscript></highlight>J<highlight><subscript>HH&Prime;</subscript></highlight>&equals;1.08 Hz), 6.82 (t, 1H, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;7.63 Hz), 6.95 (t, 1H, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;7.70 Hz), 7.11 (d, 1H, <highlight><superscript>3</superscript></highlight>J<highlight><subscript>HH&prime;</subscript></highlight>&equals;6.63 Hz); MS &lsqb;M&plus;1&rsqb;&equals;277. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 6 </heading>
</section>
<section>
<heading lvl="1">1-(3-Phenyl-2,3-dihydrobenzofuran-3-ylmethoxy)-2,2,6,6-tetramethylpiperidine </heading>
<paragraph id="P-0294" lvl="0"><number>&lsqb;0294&rsqb;</number> The procedure of Example 1 is repeated using 3.9 g (25 mmol) of 1-oxyl-2,2,6,6-tetramethyl-4-hydroxypiperidine, 6.18 g (60 mmol) of tert-butyl nitrite, 15 mg (0.025 mmol) of (S,S)-(&plus;)-N,N-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II) mmol) in 100 mL of pyridine and 11.25 g (50 mmol) of 2-(2-phenylallyloxy)-aniline in 20 mL of pyridine. The crude product obtained is purified by liquid chromatography (2.5% ethyl acetate/heptane) to give 2.5 g of an off-white oil in 27.4% yield. MS &lsqb;M&plus;1&rsqb; 366 </paragraph>
<paragraph id="P-0295" lvl="7"><number>&lsqb;0295&rsqb;</number> Raw Materials </paragraph>
<paragraph id="P-0296" lvl="0"><number>&lsqb;0296&rsqb;</number> Wax samples are supplied by the Candle-Lite Corporation. These samples contain dyes and fragrances. </paragraph>
<paragraph id="P-0297" lvl="0"><number>&lsqb;0297&rsqb;</number> The UV absorbers and hindered amine stabilizers are obtained from the Ciba Speciality Chemicals Corporation. </paragraph>
<paragraph id="P-0298" lvl="7"><number>&lsqb;0298&rsqb;</number> Sample Preparation </paragraph>
<paragraph id="P-0299" lvl="0"><number>&lsqb;0299&rsqb;</number> The wax samples obtained from the Candle-Lite Corporation already contain a dye and a fragrance (scent). In these cases, the wax is melted and the appropriate stabilizer(s) is (are) added and dissolved in the molten wax. The stabilized wax is then poured into five (5) 44 mm diameter aluminum pans giving five (5) wax disks. </paragraph>
<paragraph id="P-0300" lvl="7"><number>&lsqb;0300&rsqb;</number> Sample Exposure </paragraph>
<paragraph id="P-0301" lvl="0"><number>&lsqb;0301&rsqb;</number> Triplicate samples of each disk are exposed under a bank of six (6) cool-white fluorescent lamps (40 watts) or under a bank of six (6) UV lamps having a wavelength of 368 nm with the test samples being twelve (12) inches (30.48 cm) below the lamps. </paragraph>
<paragraph id="P-0302" lvl="0"><number>&lsqb;0302&rsqb;</number> Dye color fade (or color change) is measured by a Macbeth ColorEye Spectrophotometer with a 6 inch integrating sphere. The conditions are: 10 degree observer, D65 illuminant and 8 degree viewing angle. </paragraph>
<paragraph id="P-0303" lvl="0"><number>&lsqb;0303&rsqb;</number> Initial color measurements are taken using the above parameters. The L, a and b values are calculated using the CIE system from the reflectance values. YI is calculated from the L, a and b values. Subsequent measurements are taken at specified intervals. Delta L, a, b and YI values are simply the difference between the initial values and the values at each interval. Delta(A) E is calculated as follows: </paragraph>
<paragraph lvl="0"><in-line-formula>&lsqb;(Delta <highlight><italic>L</italic></highlight>)<highlight><superscript>2</superscript></highlight>&plus;(Delta <highlight><italic>a</italic></highlight>)<highlight><superscript>2</superscript></highlight>&plus;(Delta <highlight><italic>b</italic></highlight>)<highlight><superscript>2</superscript></highlight>&rsqb;<highlight><superscript>&frac12;</superscript></highlight>&equals;Delta <highlight><italic>E. </italic></highlight></in-line-formula></paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 7 </heading>
</section>
<section>
<heading lvl="1">Color Fade of White Scented Candle Wax Under Fluorescent Lamp Exposure </heading>
<paragraph id="P-0304" lvl="0"><number>&lsqb;0304&rsqb;</number> A variety of different stabilizers are evaluated in white scented candle wax obtained from the Candle-Lite Corporation under fluorescent lamp exposure. The &Dgr;E values represent the change in color after the indicated days of exposure. A low &Dgr;E value indicates less change in color and is highly desired.  
<table-cwu id="TABLE-US-00004">
<number>4</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="5">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="63PT" align="left"/>
<colspec colname="2" colwidth="56PT" align="center"/>
<colspec colname="3" colwidth="35PT" align="center"/>
<colspec colname="4" colwidth="49PT" align="center"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>&Dgr;E after</entry>
<entry>&Dgr;E after</entry>
<entry>&Dgr;E after</entry>
</row>
<row>
<entry></entry>
<entry>Sample* (wt % add)</entry>
<entry>5.9 days</entry>
<entry>11.8 days</entry>
<entry>35 days</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
<entry>Blank (no add)</entry>
<entry>42.90</entry>
<entry>45.50</entry>
<entry>45.14</entry>
</row>
<row>
<entry></entry>
<entry>A (0.15%) &plus;</entry>
</row>
<row>
<entry></entry>
<entry>B (0.15%)</entry>
<entry>24.48</entry>
<entry>26.36</entry>
<entry>27.80</entry>
</row>
<row>
<entry></entry>
<entry>C (0.15%) &plus;</entry>
</row>
<row>
<entry></entry>
<entry>D (0.15%)</entry>
<entry>13.34</entry>
<entry>15.26</entry>
<entry>18.16</entry>
</row>
<row>
<entry></entry>
<entry>C (0.15% &plus;</entry>
</row>
<row>
<entry></entry>
<entry>E (0.15%)</entry>
<entry>&ensp;8.12</entry>
<entry>10.57</entry>
<entry>12.75</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="left"><footnote id="FOO-00001">*A is 2-(2-hydroxy-5-tert-octylphenyl)-2H-benzotriazole, TINUVIN&thinsp;&reg; 329, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="left"><footnote id="FOO-00002">B is bis(1,2,2,6,6-pentamethylpiperidin-4-yl) sebacate, TINUVIN&thinsp;&reg; 292, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="left"><footnote id="FOO-00003">C is octyl 3-(benzotriazol-2-yl)-5-tert-butyl-4-hydroxyhydrocinnamate, TINUVIN&thinsp;&reg; 384, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="left"><footnote id="FOO-00004">D is bis(1-octyloxy-2,2,6,6-tertramethylpiperidin-4-yl) sebacate. TINVVIN&thinsp;&reg; 123, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="left"><footnote id="FOO-00005">E is 1-(2,3-dihydrobenzofuran-3-yl-methoxy)-2,2,6,6-tetramethylpiperidine, the compound of Example 1. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0305" lvl="0"><number>&lsqb;0305&rsqb;</number> These data show that the instant compound of Example 1 protects white scented candle from discoloring better than do conventional stabilizer systems. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 8 </heading>
</section>
<section>
<heading lvl="1"></heading>
<paragraph id="P-0306" lvl="0"><number>&lsqb;0306&rsqb;</number> Color Fade of Gray Scented Candle Wax Under Fluorescent Lamp Exposure </paragraph>
<paragraph id="P-0307" lvl="0"><number>&lsqb;0307&rsqb;</number> A variety of different stabilizers are evaluated in gray scented candle wax obtained from the Candle-Lite Corporation under fluorescent lamp exposure. The &Dgr;E values represent the change in color after the indicated days of exposure. A low &Dgr;E value indicates less change in color and is highly desired.  
<table-cwu id="TABLE-US-00005">
<number>5</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="4">
<colspec colname="1" colwidth="63PT" align="left"/>
<colspec colname="2" colwidth="56PT" align="center"/>
<colspec colname="3" colwidth="35PT" align="center"/>
<colspec colname="4" colwidth="63PT" align="center"/>
<thead>
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="4" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry>&Dgr;E after</entry>
<entry>&Dgr;E after</entry>
<entry>&Dgr;E after</entry>
</row>
<row>
<entry>Sample* (wt % add)</entry>
<entry>4.9 days</entry>
<entry>15.5 days</entry>
<entry>33.9 days</entry>
</row>
<row><entry namest="1" nameend="4" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry>Blank (no add)</entry>
<entry>9.66</entry>
<entry>14.07</entry>
<entry>16.01</entry>
</row>
<row>
<entry>C (0.15%) &plus;</entry>
</row>
<row>
<entry>D (0.15%)</entry>
<entry>1.04</entry>
<entry>&ensp;1.82</entry>
<entry>&ensp;3.16</entry>
</row>
<row>
<entry>C (0.15%) &plus;</entry>
</row>
<row>
<entry>E (0.15%)</entry>
<entry>1.06</entry>
<entry>&ensp;1.75</entry>
<entry>&ensp;3.22</entry>
</row>
<row><entry namest="1" nameend="4" align="center" rowsep="1"></entry>
</row>
<row>
<entry namest="1" nameend="4" align="left"><footnote id="FOO-00006">*C is octyl 3-(benzotriazol-2-yl)-5-tert-butyl-4-hydroxyhydrocinnamate, TINUVIN&thinsp;&reg; 384, CIBA. </footnote></entry>
</row>
<row>
<entry namest="1" nameend="4" align="left"><footnote id="FOO-00007">D is bis(1-octyloxy-2,2,6,6-tertramethylpiperidin-4-yl) sebacate. TINVVIN&thinsp;&reg; 123, CIBA. </footnote></entry>
</row>
<row>
<entry namest="1" nameend="4" align="left"><footnote id="FOO-00008">E is 1-(2,3-dihydrobenzofuran-3-yl-methoxy)-2,2,6,6-tetramethylpiperidine, the compound of Example 1. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0308" lvl="0"><number>&lsqb;0308&rsqb;</number> These data show that the instant compound of Example 1 protects gray scented candle from discoloring as well as do conventional stabilizer systems. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 9 </heading>
</section>
<section>
<heading lvl="1">Color Fade of Pink Potpouri Scented Candle Wax Under Fluorescent Lamp Exposure </heading>
<paragraph id="P-0309" lvl="0"><number>&lsqb;0309&rsqb;</number> An instant compound is evaluated in pink potpouri scented candle wax obtained from the Candle-Lite Corporation under fluorescent lamp exposure. The &Dgr;E values represent the change in color after the indicated days of exposure. A low &Dgr;E value indicates less change in color and is highly desired.  
<table-cwu id="TABLE-US-00006">
<number>6</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="5">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="63PT" align="left"/>
<colspec colname="2" colwidth="49PT" align="center"/>
<colspec colname="3" colwidth="35PT" align="center"/>
<colspec colname="4" colwidth="56PT" align="center"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>&Dgr;E after</entry>
<entry>&Dgr;E after</entry>
<entry>&Dgr;E after</entry>
</row>
<row>
<entry></entry>
<entry>Sample* (wt % add)</entry>
<entry>5.9 days</entry>
<entry>11.8 days</entry>
<entry>35 days</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="5">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="63PT" align="left"/>
<colspec colname="2" colwidth="49PT" align="char" char="."/>
<colspec colname="3" colwidth="35PT" align="char" char="."/>
<colspec colname="4" colwidth="56PT" align="char" char="."/>
<tbody valign="top">
<row>
<entry></entry>
<entry>Blank (no add)</entry>
<entry>42.90</entry>
<entry>45.50</entry>
<entry>45.14</entry>
</row>
<row>
<entry></entry>
<entry>C (0.15%) &plus;</entry>
</row>
<row>
<entry></entry>
<entry>E (0.15%)</entry>
<entry>2.83</entry>
<entry>5.09</entry>
<entry>7.03</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="left"><footnote id="FOO-00009">*C is octyl 3-(benzotriazol-2-yl)-5-tert-butyl-4-hydroxyhydrocinnamate, TINUVIN&thinsp;&reg; 384, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="left"><footnote id="FOO-00010">E is 1-(2,3-dihydrobenzofuran-3-yl-methoxy)-2,2,6,6-tetramethylpiperidine, the compound of Example 1. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0310" lvl="0"><number>&lsqb;0310&rsqb;</number> These data show that the instant compound of Example 1 provides the pink potpouri scented candle good protection from discoloring. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 10 </heading>
</section>
<section>
<heading lvl="1">Color Fade of White Scented Candle Wax Under UV Lamp Exposure </heading>
<paragraph id="P-0311" lvl="0"><number>&lsqb;0311&rsqb;</number> A variety of different stabilizers are evaluated in white scented candle wax obtained from the Candle-Lite Corporation under UV lamp exposure. The &Dgr;E values represent the change in color after the indicated days of exposure. A low &Dgr;E value indicates less change in color and is highly desired.  
<table-cwu id="TABLE-US-00007">
<number>7</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="5">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="63PT" align="left"/>
<colspec colname="2" colwidth="49PT" align="center"/>
<colspec colname="3" colwidth="35PT" align="center"/>
<colspec colname="4" colwidth="56PT" align="center"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>&Dgr;E after</entry>
<entry>&Dgr;E after</entry>
<entry>&Dgr;E after</entry>
</row>
<row>
<entry></entry>
<entry>Sample* (wt % add)</entry>
<entry>4 days</entry>
<entry>10.1 days</entry>
<entry>33 days</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="5">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="63PT" align="left"/>
<colspec colname="2" colwidth="49PT" align="char" char="."/>
<colspec colname="3" colwidth="35PT" align="char" char="."/>
<colspec colname="4" colwidth="56PT" align="char" char="."/>
<tbody valign="top">
<row>
<entry></entry>
<entry>Blank (no add)</entry>
<entry>27.56</entry>
<entry>32.71</entry>
<entry>34.68</entry>
</row>
<row>
<entry></entry>
<entry>A (0.15%) &plus;</entry>
</row>
<row>
<entry></entry>
<entry>B (0.15%)</entry>
<entry>18.66</entry>
<entry>23.57</entry>
<entry>25.09</entry>
</row>
<row>
<entry></entry>
<entry>C (0.15%) &plus;</entry>
</row>
<row>
<entry></entry>
<entry>D (0.15%)</entry>
<entry>5.16</entry>
<entry>6.68</entry>
<entry>10.27</entry>
</row>
<row>
<entry></entry>
<entry>C (0.15%) &plus;</entry>
</row>
<row>
<entry></entry>
<entry>E (0.15%)</entry>
<entry>2.26</entry>
<entry>4.49</entry>
<entry>7.71</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="left"><footnote id="FOO-00011">*A is 2-(2-hydroxy-5-tert-octylphenyl)-2H-benzotriazole, TINUVIN&thinsp;&reg; 329, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="left"><footnote id="FOO-00012">B is bis(1,2,2,6,6-pentamethylpiperidin-4-yl) sebacate, TINUVIN&thinsp;&reg; 292, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="left"><footnote id="FOO-00013">C is octyl 3-(benzotriazol-2-yl)-5-tert-butyl-4-hydroxyhydrocinnamate, TINUVIN&thinsp;&reg; 384, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="left"><footnote id="FOO-00014">D is bis(1-octyloxy-2,2,6,6-tetramethylpiperidin-4-yl) sebacate. TINVVIN&thinsp;&reg; 123, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="left"><footnote id="FOO-00015">E is 1-(2,3-dihydrobenzofuran-3-yl-methoxy)-2,2,6,6-tetramethylpiperidine, the compound of Example 1. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0312" lvl="7"><number>&lsqb;0312&rsqb;</number> D is bis(1-octyloxy-2,2,6,6-tetramethylpiperidin-4-yl) sebacate. TINVVIN&reg; 123, CIBA. E is 1-(2,3-dihydrobenzofuran-3-yl-methoxy)-2,2,6,6-tetramethylpiperidine, the compound of Example 1. </paragraph>
<paragraph id="P-0313" lvl="0"><number>&lsqb;0313&rsqb;</number> These data show that the instant compound of Example 1 protects white scented candle from discoloring far better than do conventional stabilizer systems. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 11 </heading>
</section>
<section>
<heading lvl="1">Color Fade of Gray Scented Candle Wax Under UV Lamp Exposure </heading>
<paragraph id="P-0314" lvl="0"><number>&lsqb;0314&rsqb;</number> A variety of different stabilizers are evaluated in gray scented candle wax obtained from the Candle-Lite Corporation under UV lamp exposure. The &Dgr;E values represent the change in color after the indicated days of exposure. A low &Dgr;E value indicates less change in color and is highly desired.  
<table-cwu id="TABLE-US-00008">
<number>8</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="5">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="70PT" align="left"/>
<colspec colname="2" colwidth="42PT" align="center"/>
<colspec colname="3" colwidth="28PT" align="center"/>
<colspec colname="4" colwidth="63PT" align="center"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>&Dgr;E after</entry>
<entry>&Dgr;E after</entry>
<entry>&Dgr;E after</entry>
</row>
<row>
<entry></entry>
<entry>Sample* (wt % add)</entry>
<entry>2.8 days</entry>
<entry>8.9 days</entry>
<entry>22.6 days</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="5">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="70PT" align="left"/>
<colspec colname="2" colwidth="42PT" align="char" char="."/>
<colspec colname="3" colwidth="28PT" align="char" char="."/>
<colspec colname="4" colwidth="63PT" align="char" char="."/>
<tbody valign="top">
<row>
<entry></entry>
<entry>Blank (no add)</entry>
<entry>22.2</entry>
<entry>28.98</entry>
<entry>30.07</entry>
</row>
<row>
<entry></entry>
<entry>C (0.15%) &plus;</entry>
</row>
<row>
<entry></entry>
<entry>D (0.15%)</entry>
<entry>1.70</entry>
<entry>3.47</entry>
<entry>5.11</entry>
</row>
<row>
<entry></entry>
<entry>C (0.15%) &plus;</entry>
</row>
<row>
<entry></entry>
<entry>E (0.15%)</entry>
<entry>1.22</entry>
<entry>2.71</entry>
<entry>4.06</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="left"><footnote id="FOO-00016">*C is octyl 3-(benzotriazol-2-yl)-5-tert-butyl-4-hydroxyhydrocinnamate, TINUVIN&thinsp;&reg; 384, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="left"><footnote id="FOO-00017">D is bis(1-octyloxy-2,2,6,6-tetramethylpiperidin-4-yl) sebacate. TINVVIN&thinsp;&reg; 123, CIBA. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="left"><footnote id="FOO-00018">E is 1-(2,3-dihydrobenzofuran-3-yl-methoxy)-2,2,6,6-tetramethylpiperidine, the compound of Example 1. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0315" lvl="0"><number>&lsqb;0315&rsqb;</number> These data show that the instant compound of Example 1 protects gray scented candle from discoloring better than do conventional stabilizer systems. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 12 </heading>
</section>
<section>
<heading lvl="1">Color Fade of Pink Potpouri Scented Candle Wax Under UV Lamp Exposure </heading>
<paragraph id="P-0316" lvl="0"><number>&lsqb;0316&rsqb;</number> An instant compound is evaluated in pink potpouri scented candle wax obtained from the Candle-Lite Corporation under fluorescent lamp exposure. The &Dgr;E values represent the change in color after the indicated days of exposure. A low &Dgr;E value indicates less change in color and is highly desired.  
<table-cwu id="TABLE-US-00009">
<number>9</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="4">
<colspec colname="1" colwidth="63PT" align="left"/>
<colspec colname="2" colwidth="56PT" align="center"/>
<colspec colname="3" colwidth="35PT" align="center"/>
<colspec colname="4" colwidth="63PT" align="center"/>
<thead>
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="4" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry>&Dgr;E after</entry>
<entry>&Dgr;E after</entry>
<entry>&Dgr;E after</entry>
</row>
<row>
<entry>Sample* (wt % add)</entry>
<entry>7.6 days</entry>
<entry>18.4 days</entry>
<entry>36.7 days</entry>
</row>
<row><entry namest="1" nameend="4" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="4">
<colspec colname="1" colwidth="63PT" align="left"/>
<colspec colname="2" colwidth="56PT" align="char" char="."/>
<colspec colname="3" colwidth="35PT" align="char" char="."/>
<colspec colname="4" colwidth="63PT" align="char" char="."/>
<tbody valign="top">
<row>
<entry>Blank (no add)</entry>
<entry>16.16</entry>
<entry>17.47</entry>
<entry>20.27</entry>
</row>
<row>
<entry>C (0.15%) &plus;</entry>
</row>
<row>
<entry>E (0.15%)</entry>
<entry>5.55</entry>
<entry>6.16</entry>
<entry>8.06</entry>
</row>
<row><entry namest="1" nameend="4" align="center" rowsep="1"></entry>
</row>
<row>
<entry namest="1" nameend="4" align="left"><footnote id="FOO-00019">*C is octyl 3-(benzotriazol-2-yl)-5-tert-butyl-4-hydroxyhydrocinnamate, TINUVIN&thinsp;&reg; 384, CIBA. </footnote></entry>
</row>
<row>
<entry namest="1" nameend="4" align="left"><footnote id="FOO-00020">E is 1-(2,3-dihydrobenzofuran-3-yl-methoxy)-2,2,6,6-tetramethylpiperidine, the compound of Example 1. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0317" lvl="0"><number>&lsqb;0317&rsqb;</number> These data show that the instant compound of Example 1 provides the pink potpouri scented candle good protection from discoloring. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 13 </heading>
<paragraph id="P-0318" lvl="0"><number>&lsqb;0318&rsqb;</number> Molding grade polypropylene is dry blended with test additives and then melt compounded into pellets. The pelletized fully formulated resin is then injection molded into test specimens unsing a Boy 50M laboratory model injection molder. </paragraph>
<paragraph id="P-0319" lvl="0"><number>&lsqb;0319&rsqb;</number> Test plaques are mounted in metal frames and exposed in an Atlas Ci65 Xenon Arc Weather-Ometer with intermittent light/dark cycles and water spray following ASTM G26 test procedure. Specimens are tested at periodic intervals for changes in tensile properties. Failure in this test is determined by the observation of the loss of tensile properties. The longer it takes for the loss in properties to occur, the more effective is the stabilizer system. </paragraph>
<paragraph id="P-0320" lvl="0"><number>&lsqb;0320&rsqb;</number> The test samples containing the instant compounds of Examples 1, 4, 5 and 6 exhibit good light stabilization properties. </paragraph>
</section>
</detailed-description>
</subdoc-description>
<subdoc-claims>
<heading lvl="1">What is claimed is: </heading>
<claim id="CLM-00001">
<claim-text><highlight><bold>1</bold></highlight>. A process for preparing a sterically hindered N-alkyloxyamine of formula I, II or </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00005">
<number>5</number>
<image id="EMI-C00005" he="211.46265" wi="198.02475" file="US20030000129A1-20030102-C00005.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00005" file="US20030000129A1-20030102-C00005.CDX"/>
<chemistry-mol-file id="CHEMMOL-00005" file="US20030000129A1-20030102-C00005.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>which comprises 
<claim-text>reacting a sterically hindered nitroxyl compound of formula IV, V or VI </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00006">
<number>6</number>
<image id="EMI-C00006" he="211.46265" wi="198.02475" file="US20030000129A1-20030102-C00006.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00006" file="US20030000129A1-20030102-C00006.CDX"/>
<chemistry-mol-file id="CHEMMOL-00006" file="US20030000129A1-20030102-C00006.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>with a diazonium salt of an aromatic amine of formula VII </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00007">
<number>7</number>
<image id="EMI-C00007" he="118.1061" wi="198.02475" file="US20030000129A1-20030102-C00007.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00007" file="US20030000129A1-20030102-C00007.CDX"/>
<chemistry-mol-file id="CHEMMOL-00007" file="US20030000129A1-20030102-C00007.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>in the presence of a transition-metal catalyst </claim-text>
<claim-text>wherein </claim-text>
<claim-text>X is &mdash;CH<highlight><subscript>2</subscript></highlight>&mdash;, &mdash;O&mdash;, &mdash;S&mdash; or &mdash;NR<highlight><subscript>8</subscript></highlight>&mdash; where R<highlight><subscript>8 </subscript></highlight>is hydrogen or alkyl of 1 to 12 carbon atoms, </claim-text>
<claim-text>R<highlight><subscript>6 </subscript></highlight>and R<highlight><subscript>7 </subscript></highlight>are independently alkyl of 1 to 8 carbon atoms, or R<highlight><subscript>6 </subscript></highlight>and R<highlight><subscript>7 </subscript></highlight>together are tetramethylene or pentamethylene, </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00008">
<number>8</number>
<image id="EMI-C00008" he="84.00105" wi="105.8589" file="US20030000129A1-20030102-C00008.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00008" file="US20030000129A1-20030102-C00008.CDX"/>
<chemistry-mol-file id="CHEMMOL-00008" file="US20030000129A1-20030102-C00008.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>R is hydrogen, alkyl of 1 to 18 carbon atoms, aralkyl of 7 to 15 carbon atoms, aryl of 6 to 10 carbon atoms, hydroxyl, carboxyl, amino, alkylamino of 1 to 18 carbon atoms, dialkylamino of 2 to 36 carbon atoms, oxo, alkylthio of 1 to 18 carbon atoms, alkoxy of 1 to 18 carbon atoms, aryloxy of 7 to 15 carbon atoms, alkylcarbonyloxy of 2 to 18 carbon atoms or alkylcarbonylamino of 2 to 18 carbon atoms, </claim-text>
<claim-text>G<highlight><subscript>1 </subscript></highlight>to G<highlight><subscript>4 </subscript></highlight>are independently hydrogen, halogen, nitro, cyano, alkyl of 1 to 18 carbon atoms, aralkyl of 7 to 15 carbon atoms, aryl of 6 to 10 carbon atoms, hydroxyl, carboxyl, alkylthio of 1 to 18 carbon atoms, alkoxy of 1 to 18 carbon atoms, aryloxy of 7 to 15 carbon atoms, alkylcarbonyloxy of 1 to 18 carbon atoms, alkylsulfonyl of 1 to 18 carbon atoms, arylsulfonyl of 6 to 15 carbon atoms, sulfo or phosphono, or any two vicinal substituents connected together to form a mono or polycyclic ring, so that formula VII can represent inter alia 1-naphthylamine or 2-naphthylamine, and </claim-text>
<claim-text>G<highlight><subscript>5 </subscript></highlight>to G<highlight><subscript>9 </subscript></highlight>are independently hydrogen, alkyl of 1 to 18 carbon atoms, aralkyl of 7 to 15 carbon atoms or aryl of 6 to 10 carbon atoms. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00002">
<claim-text><highlight><bold>2</bold></highlight>. A process according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> where in the compound of formula I or formula II, X is methylene. </claim-text>
</claim>
<claim id="CLM-00003">
<claim-text><highlight><bold>3</bold></highlight>. A process according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> where in the compound of formula I or formula II, R is hydrogen, hydroxyl, oxo or acetamido. </claim-text>
</claim>
<claim id="CLM-00004">
<claim-text><highlight><bold>4</bold></highlight>. A process according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> where in the compound of formula I, II or III, one of G<highlight><subscript>1 </subscript></highlight>to G<highlight><subscript>9 </subscript></highlight>is phenyl. </claim-text>
</claim>
<claim id="CLM-00005">
<claim-text><highlight><bold>5</bold></highlight>. A process according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the diazonium salt of the aromatic amine of formula VII is prepared by reaction with an alkyl nitrite. </claim-text>
</claim>
<claim id="CLM-00006">
<claim-text><highlight><bold>6</bold></highlight>. A process according to <dependent-claim-reference depends_on="CLM-00005">claim 5</dependent-claim-reference> wherein the alkyl nitrite is tert-butyl nitrite. </claim-text>
</claim>
<claim id="CLM-00007">
<claim-text><highlight><bold>7</bold></highlight>. A process according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein reaction is carried out in chlorobenzene as solvent at a temperature of 0 to 100&deg; C. </claim-text>
</claim>
<claim id="CLM-00008">
<claim-text><highlight><bold>8</bold></highlight>. A process according to <dependent-claim-reference depends_on="CLM-00007">claim 7</dependent-claim-reference> wherein the temperature is between 20 and 70&deg; C. </claim-text>
</claim>
<claim id="CLM-00009">
<claim-text><highlight><bold>9</bold></highlight>. A process according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the reaction is carried out with pyridine present as a reaction component or as the solvent. </claim-text>
</claim>
<claim id="CLM-00010">
<claim-text><highlight><bold>10</bold></highlight>. A process according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the transition metal is a metal of Group 4, 5, 6, 7, 8, 9 or 10 of the periodic table. </claim-text>
</claim>
<claim id="CLM-00011">
<claim-text><highlight><bold>11</bold></highlight>. A process according to <dependent-claim-reference depends_on="CLM-00011">claim 10</dependent-claim-reference> wherein the transition metal is copper(I), copper(II), cobalt(II), manganese(II) or gold(I). </claim-text>
</claim>
<claim id="CLM-00012">
<claim-text><highlight><bold>12</bold></highlight>. A process according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the process is carried out in the presence of 0.05 mole % to stoichiometric quantities of the transition metal catalyst. </claim-text>
</claim>
<claim id="CLM-00013">
<claim-text><highlight><bold>13</bold></highlight>. A process according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the the transition metal catalyst is ligated by a salcoamine ligand such as (S,S)-(&plus;)-N,N-bis(3,5-di-test-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II) or N,N-bis(salicylidene)ethylenediaminocobalt(II). </claim-text>
</claim>
<claim id="CLM-00014">
<claim-text><highlight><bold>14</bold></highlight>. A process according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the compound of formula I, II or III is 
<claim-text>(i) 1-(2,3-dihydrobenzofuran-3-ylmethoxy)-2,2,6,6-tetramethylpiperidine; </claim-text>
<claim-text>(ii) the cis and trans isomers of 1-(2,3-dihydrobenzofuran-3-ylmethoxy)-2,2,6,6-tetramethylpiperidine; </claim-text>
<claim-text>(iii) N,N-di-tert-butyl-N-(2,3-dihydrobenzofuran-3-ylmethoxy)amine; or </claim-text>
<claim-text>(iv) 1-(3-phenyl-2,3-dihydrobenzofuran-3-ylmethoxy)-2,2,6,6-tetramethyl-piperidine. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00015">
<claim-text><highlight><bold>15</bold></highlight>. A process according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the diazonium salt of the aromatic amine of formula VII is prepared by reaction of the amine with an alkali metal nitrite and an aqueous mineral acid. </claim-text>
</claim>
<claim id="CLM-00016">
<claim-text><highlight><bold>16</bold></highlight>. A compound which is the cis or trans isomer of 1-(2,3-dihydrobenzofuran-3-yl-methoxy)-2,2,6,6-tetramethylpiperidine or is 1-(3-phenyl-2,3-dihydrobenzofuran-3-ylmethoxy)-2,2,6,6-tetramethylpiperidine. </claim-text>
</claim>
<claim id="CLM-00017">
<claim-text><highlight><bold>17</bold></highlight>. A composition stabilized which comprises 
<claim-text>(a) an organic material subject to degradation by heat, light or oxygen, and </claim-text>
<claim-text>(b) an effective stabilizing amount of a compound of formula I, II or III as described in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00018">
<claim-text><highlight><bold>18</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00011">claim 17</dependent-claim-reference> which comprises 
<claim-text>(a) candle wax which is white and scented, white and unscented, dyed and scented, dyed and unscented, dipped and scented or dipped and unscented, and </claim-text>
<claim-text>(b) an effective stabilizing amount of a compound of formula I, II or III </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00009">
<number>9</number>
<image id="EMI-C00009" he="211.46265" wi="198.02475" file="US20030000129A1-20030102-C00009.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00009" file="US20030000129A1-20030102-C00009.CDX"/>
<chemistry-mol-file id="CHEMMOL-00009" file="US20030000129A1-20030102-C00009.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>which comprises </claim-text>
<claim-text>reacting a sterically hindered nitroxyl compound of formula IV, V or VI </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00010">
<number>10</number>
<image id="EMI-C00010" he="211.46265" wi="198.02475" file="US20030000129A1-20030102-C00010.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00010" file="US20030000129A1-20030102-C00010.CDX"/>
<chemistry-mol-file id="CHEMMOL-00010" file="US20030000129A1-20030102-C00010.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>with a diazonium salt of an aromatic amine of formula VII </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00011">
<number>11</number>
<image id="EMI-C00011" he="118.1061" wi="198.02475" file="US20030000129A1-20030102-C00011.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00011" file="US20030000129A1-20030102-C00011.CDX"/>
<chemistry-mol-file id="CHEMMOL-00011" file="US20030000129A1-20030102-C00011.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>in the presence of a transition-metal catalyst </claim-text>
<claim-text>wherein </claim-text>
<claim-text>X is &mdash;CH<highlight><subscript>2</subscript></highlight>&mdash;, &mdash;O&mdash;, &mdash;S&mdash; or &mdash;NR<highlight><subscript>8</subscript></highlight>&mdash; where R<highlight><subscript>8 </subscript></highlight>is hydrogen or alkyl of 1 to 12 carbon atoms, </claim-text>
<claim-text>R<highlight><subscript>6 </subscript></highlight>and R<highlight><subscript>7 </subscript></highlight>are independently alkyl of 1 to 8 carbon atoms, or R<highlight><subscript>6 </subscript></highlight>and R<highlight><subscript>7 </subscript></highlight>together are tetramethylene or pentamethylene, </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00012">
<number>12</number>
<image id="EMI-C00012" he="84.00105" wi="105.8589" file="US20030000129A1-20030102-C00012.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00012" file="US20030000129A1-20030102-C00012.CDX"/>
<chemistry-mol-file id="CHEMMOL-00012" file="US20030000129A1-20030102-C00012.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>R is hydrogen, alkyl of 1 to 18 carbon atoms, aralkyl of 7 to 15 carbon atoms, aryl of 6 to 10 carbon atoms, hydroxyl, carboxyl, amino, alkylamino of 1 to 18 carbon atoms, dialkylamino of 2 to 36 carbon atoms, oxo, alkylthio of 1 to 18 carbon atoms, alkoxy of 1 to 18 carbon atoms, aryloxy of 7 to 15 carbon atoms, alkylcarbonyloxy of 2 to 18 carbon atoms or alkylcarbonylamino of 2 to 18 carbon atoms, </claim-text>
<claim-text>G<highlight><subscript>1 </subscript></highlight>to G<highlight><subscript>4 </subscript></highlight>are independently hydrogen, halogen, nitro, cyano, alkyl of 1 to 18 carbon atoms, aralkyl of 7 to 15 carbon atoms, aryl of 6 to 10 carbon atoms, hydroxyl, carboxyl, alkylthio of 1 to 18 carbon atoms, alkoxy of 1 to 18 carbon atoms, aryloxy of 7 to 15 carbon atoms, alkylcarbonyloxy of 1 to 18 carbon atoms, alkylsulfonyl of 1 to 18 carbon atoms, arylsulfonyl of 6 to 15 carbon atoms, sulfo or phosphono, or any two vicinal substituents connected together to form a mono or polycyclic ring, so that formula VII can represent inter alia 1-naphthylamine or 2-naphthylamine, and </claim-text>
<claim-text>G<highlight><subscript>5 </subscript></highlight>to G<highlight><subscript>9 </subscript></highlight>are independently hydrogen, alkyl of 1 to 18 carbon atoms, aralkyl of 7 to 15 carbon atoms or aryl of 6 to 10 carbon atoms. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00019">
<claim-text><highlight><bold>19</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00011">claim 18</dependent-claim-reference> which additionally contains an effective stabilizing amount of a UV absorber.</claim-text>
</claim>
</subdoc-claims>
</patent-application-publication>
